data_2ih6_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ih6 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.331 41.8 t . . . . . 0 CA--C 1.573 1.828 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.472 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 17.7 p -139.61 -148.94 0.27 Allowed 'General case' 0 CA--C 1.576 1.957 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -160.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 38.1 t -121.42 84.87 2.31 Favored 'General case' 0 CA--C 1.572 1.821 0 O-C-N 120.36 -1.462 . . . . 0.0 112.075 148.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 145.54 42.82 0.04 OUTLIER Glycine 0 N--CA 1.503 3.137 0 N-CA-C 118.631 2.212 . . . . 0.0 118.631 176.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.572 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 1.2 t80 -161.96 152.63 14.71 Favored Pre-proline 0 CA--C 1.58 2.106 0 CA-C-N 118.712 1.256 . . . . 0.0 109.121 -174.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -30.5 -55.94 0.2 Allowed 'Trans proline' 0 CA--C 1.569 2.238 0 N-CA-C 121.594 3.651 . . . . 0.0 121.594 174.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.6 mp -79.62 -7.8 58.77 Favored 'General case' 0 CA--C 1.579 2.058 0 N-CA-C 116.628 2.085 . . . . 0.0 116.628 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.572 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 96.7 m -68.0 145.15 54.76 Favored 'General case' 0 CA--C 1.568 1.664 0 N-CA-C 117.564 2.431 . . . . 0.0 117.564 -161.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 27.1 p80 . . . . . 0 CA--C 1.584 2.265 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 -175.259 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.303 20.1 t . . . . . 0 CA--C 1.569 1.678 0 N-CA-C 111.122 0.045 . . . . 0.0 111.122 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.477 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 17.1 p -144.13 -152.23 0.41 Allowed 'General case' 0 CA--C 1.575 1.921 0 N-CA-C 115.688 1.736 . . . . 0.0 115.688 -161.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 36.8 t -118.87 83.65 2.06 Favored 'General case' 0 CA--C 1.575 1.941 0 O-C-N 120.317 -1.49 . . . . 0.0 111.862 146.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 147.96 40.13 0.04 OUTLIER Glycine 0 N--CA 1.5 2.939 0 N-CA-C 119.83 2.692 . . . . 0.0 119.83 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.599 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 0.7 OUTLIER -162.04 155.63 17.95 Favored Pre-proline 0 CA--C 1.581 2.138 0 CA-C-N 119.445 1.623 . . . . 0.0 109.271 -175.918 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -31.16 -62.35 0.12 Allowed 'Trans proline' 0 CA--C 1.568 2.217 0 C-N-CA 124.272 3.315 . . . . 0.0 120.685 173.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.5 mp -73.62 -8.78 57.32 Favored 'General case' 0 CA--C 1.577 1.989 0 N-CA-C 117.477 2.399 . . . . 0.0 117.477 178.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.599 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 82.4 m -59.88 137.55 58.04 Favored 'General case' 0 CA--C 1.566 1.561 0 N-CA-C 117.529 2.418 . . . . 0.0 117.529 -161.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 30.2 p80 . . . . . 0 CA--C 1.578 2.04 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 -176.214 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.262 35.8 t . . . . . 0 N--CA 1.493 1.694 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.431 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 20.9 p -159.96 -155.35 0.44 Allowed 'General case' 0 CA--C 1.575 1.938 0 C-N-CA 124.041 0.937 . . . . 0.0 113.315 -161.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 51.9 t -113.3 113.42 25.24 Favored 'General case' 0 CA--C 1.573 1.862 0 O-C-N 120.751 -1.218 . . . . 0.0 111.425 151.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 109.39 62.86 0.53 Allowed Glycine 0 N--CA 1.5 2.955 0 N-CA-C 118.353 2.101 . . . . 0.0 118.353 169.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.686 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 66.8 t80 -178.21 151.16 0.77 Allowed Pre-proline 0 CA--C 1.582 2.175 0 C-N-CA 125.224 1.409 . . . . 0.0 108.167 -167.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -32.78 -54.26 0.37 Allowed 'Trans proline' 0 CA--C 1.568 2.195 0 N-CA-C 121.418 3.584 . . . . 0.0 121.418 169.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.8 mp -84.84 2.17 43.65 Favored 'General case' 0 CA--C 1.58 2.117 0 N-CA-C 116.213 1.931 . . . . 0.0 116.213 177.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.686 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 93.7 m -92.16 129.22 38.16 Favored 'General case' 0 CA--C 1.562 1.434 0 O-C-N 119.882 -1.761 . . . . 0.0 114.248 -169.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 20.7 p80 . . . . . 0 CA--C 1.581 2.145 0 N-CA-C 117.425 2.38 . . . . 0.0 117.425 -173.081 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.299 56.1 t . . . . . 0 N--CA 1.494 1.748 0 CA-C-O 119.696 -0.192 . . . . 0.0 110.734 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 17.8 p -147.5 -152.79 0.45 Allowed 'General case' 0 CA--C 1.578 2.035 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -165.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 52.8 t -119.08 73.8 0.95 Allowed 'General case' 0 CA--C 1.576 1.979 0 O-C-N 120.521 -1.362 . . . . 0.0 112.626 154.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 152.6 57.29 0.01 OUTLIER Glycine 0 N--CA 1.502 3.08 0 N-CA-C 118.532 2.173 . . . . 0.0 118.532 173.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.572 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 5.5 t80 -174.65 155.25 2.01 Favored Pre-proline 0 CA--C 1.591 2.539 0 C-N-CA 125.16 1.384 . . . . 0.0 109.694 -172.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -37.33 -55.82 0.92 Allowed 'Trans proline' 0 CA--C 1.57 2.319 0 N-CA-C 121.62 3.662 . . . . 0.0 121.62 173.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.6 mp -78.01 -8.97 58.87 Favored 'General case' 0 CA--C 1.581 2.136 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 175.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.572 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 79.9 m -70.9 135.41 47.97 Favored 'General case' 0 CA--C 1.564 1.508 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 -177.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 33.9 p80 . . . . . 0 CA--C 1.578 2.036 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -177.479 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.283 54.8 t . . . . . 0 CA--C 1.571 1.762 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.458 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 17.9 p -153.6 -162.66 1.49 Allowed 'General case' 0 CA--C 1.575 1.921 0 N-CA-C 115.216 1.561 . . . . 0.0 115.216 -161.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 44.4 t -101.18 107.57 19.01 Favored 'General case' 0 CA--C 1.573 1.856 0 O-C-N 120.462 -1.399 . . . . 0.0 111.426 146.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 114.1 59.04 0.38 Allowed Glycine 0 N--CA 1.5 2.922 0 N-CA-C 118.101 2.0 . . . . 0.0 118.101 165.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.647 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 8.3 t80 -171.39 154.96 4.04 Favored Pre-proline 0 CA--C 1.586 2.35 0 CA-C-N 118.684 1.242 . . . . 0.0 110.75 -174.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -35.86 -53.04 0.94 Allowed 'Trans proline' 0 CA--C 1.568 2.198 0 N-CA-C 122.159 3.869 . . . . 0.0 122.159 173.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.6 mp -81.89 -13.4 57.62 Favored 'General case' 0 CA--C 1.58 2.099 0 N-CA-C 115.81 1.781 . . . . 0.0 115.81 176.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.647 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 98.6 m -68.87 148.84 49.65 Favored 'General case' 0 CA--C 1.562 1.436 0 N-CA-C 116.8 2.148 . . . . 0.0 116.8 -168.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 24.3 p80 . . . . . 0 CA--C 1.58 2.111 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 176.303 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 23.4 t . . . . . 0 N--CA 1.496 1.856 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.469 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 20.6 p -163.25 -162.8 0.78 Allowed 'General case' 0 CA--C 1.58 2.113 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -161.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 51.1 t -100.67 115.6 30.6 Favored 'General case' 0 CA--C 1.572 1.824 0 O-C-N 120.116 -1.615 . . . . 0.0 112.424 139.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 118.95 47.58 0.39 Allowed Glycine 0 N--CA 1.506 3.326 0 N-CA-C 119.77 2.668 . . . . 0.0 119.77 165.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.663 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 33.1 t80 -170.66 152.77 3.93 Favored Pre-proline 0 CA--C 1.585 2.306 0 CA-C-N 118.869 1.334 . . . . 0.0 110.39 -167.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -33.01 -56.81 0.33 Allowed 'Trans proline' 0 CA--C 1.568 2.199 0 N-CA-C 121.317 3.545 . . . . 0.0 121.317 172.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.3 mp -78.26 -11.25 59.92 Favored 'General case' 0 CA--C 1.58 2.121 0 N-CA-C 116.867 2.173 . . . . 0.0 116.867 178.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.663 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 86.4 m -73.37 155.12 39.7 Favored 'General case' 0 CA--C 1.565 1.543 0 N-CA-C 116.544 2.053 . . . . 0.0 116.544 -170.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 27.4 p80 . . . . . 0 CA--C 1.579 2.09 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 -178.464 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.325 45.3 t . . . . . 0 CA--C 1.571 1.787 0 CA-C-O 119.872 -0.109 . . . . 0.0 111.004 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 19.2 p -146.3 -155.67 0.64 Allowed 'General case' 0 CA--C 1.578 2.057 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 -160.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 43.2 t -113.58 99.93 8.11 Favored 'General case' 0 CA--C 1.57 1.736 0 O-C-N 120.061 -1.649 . . . . 0.0 110.525 139.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 138.56 33.82 0.18 Allowed Glycine 0 N--CA 1.501 3.019 0 N-CA-C 120.157 2.823 . . . . 0.0 120.157 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.58 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 11.0 t80 -163.23 155.07 15.14 Favored Pre-proline 0 CA--C 1.582 2.186 0 CA-C-N 119.002 1.401 . . . . 0.0 109.299 -178.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -34.74 -61.02 0.26 Allowed 'Trans proline' 0 CA--C 1.568 2.18 0 C-N-CA 124.381 3.387 . . . . 0.0 120.767 172.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.1 mp -73.29 -0.24 13.97 Favored 'General case' 0 CA--C 1.583 2.224 0 N-CA-C 117.282 2.327 . . . . 0.0 117.282 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.58 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 95.7 m -70.31 151.56 45.14 Favored 'General case' 0 CA--C 1.563 1.463 0 N-CA-C 116.514 2.042 . . . . 0.0 116.514 -171.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 16.5 p80 . . . . . 0 CA--C 1.579 2.096 0 N-CA-C 114.409 1.262 . . . . 0.0 114.409 176.687 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . 0.428 ' HB ' ' SG ' ' A' ' 8' ' ' CYS 0.297 53.4 t . . . . . 0 CA--C 1.572 1.8 0 N-CA-C 111.593 0.22 . . . . 0.0 111.593 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.414 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 20.3 p -156.77 -148.48 0.22 Allowed 'General case' 0 CA--C 1.581 2.171 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -161.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 15.5 t -112.09 122.99 49.29 Favored 'General case' 0 CA--C 1.573 1.862 0 O-C-N 120.353 -1.467 . . . . 0.0 111.863 155.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 97.47 60.38 0.95 Allowed Glycine 0 N--CA 1.502 3.086 0 N-CA-C 118.34 2.096 . . . . 0.0 118.34 166.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.639 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 53.0 t80 -177.81 151.05 0.82 Allowed Pre-proline 0 CA--C 1.586 2.356 0 C-N-CA 124.882 1.273 . . . . 0.0 109.192 -163.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -36.8 -63.32 0.22 Allowed 'Trans proline' 0 CA--C 1.57 2.277 0 C-N-CA 124.427 3.418 . . . . 0.0 120.34 173.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.4 mp -74.84 -15.96 60.71 Favored 'General case' 0 CA--C 1.579 2.069 0 N-CA-C 116.326 1.973 . . . . 0.0 116.326 176.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.639 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 91.4 m -71.92 141.19 49.48 Favored 'General case' 0 CA--C 1.558 1.285 0 N-CA-C 115.181 1.548 . . . . 0.0 115.181 -174.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 15.1 p80 . . . . . 0 CA--C 1.577 2.016 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 -179.532 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.277 53.6 t . . . . . 0 N--CA 1.494 1.757 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.514 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 19.3 p -152.24 -155.92 0.66 Allowed 'General case' 0 CA--C 1.574 1.867 0 C-N-CA 124.423 1.089 . . . . 0.0 113.033 -165.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 14.8 t -80.69 -54.86 5.26 Favored 'General case' 0 CA--C 1.574 1.904 0 N-CA-C 116.263 1.949 . . . . 0.0 116.263 160.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -127.37 85.94 0.33 Allowed Glycine 0 N--CA 1.495 2.581 0 CA-C-N 120.69 1.586 . . . . 0.0 115.936 -165.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.671 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 16.6 t80 -170.82 155.09 4.56 Favored Pre-proline 0 CA--C 1.583 2.241 0 C-N-CA 124.718 1.207 . . . . 0.0 110.004 -173.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -33.89 -48.94 0.54 Allowed 'Trans proline' 0 CA--C 1.566 2.116 0 N-CA-C 121.962 3.793 . . . . 0.0 121.962 173.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 8.3 mp -86.86 -13.1 45.9 Favored 'General case' 0 CA--C 1.578 2.048 0 N-CA-C 116.617 2.081 . . . . 0.0 116.617 178.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.671 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 66.3 m -70.16 166.03 20.81 Favored 'General case' 0 CA--C 1.565 1.536 0 N-CA-C 118.003 2.594 . . . . 0.0 118.003 -162.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 27.3 p80 . . . . . 0 CA--C 1.579 2.064 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 -178.085 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.292 73.5 t . . . . . 0 N--CA 1.493 1.693 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.475 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 17.0 p -147.45 -151.2 0.37 Allowed 'General case' 0 CA--C 1.575 1.933 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -161.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 11.9 t -87.51 -45.19 10.7 Favored 'General case' 0 CA--C 1.576 1.959 0 N-CA-C 115.877 1.806 . . . . 0.0 115.877 154.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -123.73 75.12 0.38 Allowed Glycine 0 N--CA 1.495 2.63 0 N-CA-C 117.253 1.661 . . . . 0.0 117.253 -167.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.607 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 2.3 t80 -167.62 152.64 6.77 Favored Pre-proline 0 CA--C 1.584 2.262 0 C-N-CA 124.939 1.296 . . . . 0.0 108.956 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -31.0 -54.69 0.24 Allowed 'Trans proline' 0 CA--C 1.569 2.274 0 N-CA-C 122.38 3.954 . . . . 0.0 122.38 173.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.1 mp -85.19 4.8 32.88 Favored 'General case' 0 CA--C 1.585 2.325 0 N-CA-C 116.682 2.104 . . . . 0.0 116.682 178.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.607 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 82.3 m -77.09 144.72 38.31 Favored 'General case' 0 CA--C 1.562 1.441 0 O-C-N 119.602 -1.936 . . . . 0.0 116.012 -167.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 35.5 p80 . . . . . 0 CA--C 1.584 2.261 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 171.924 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.281 40.7 t . . . . . 0 N--CA 1.496 1.838 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.502 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 17.6 p -150.94 -147.32 0.23 Allowed 'General case' 0 CA--C 1.575 1.935 0 C-N-CA 124.116 0.966 . . . . 0.0 113.523 -164.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 20.8 t -93.79 -56.46 2.88 Favored 'General case' 0 CA--C 1.577 2.007 0 O-C-N 120.733 -1.23 . . . . 0.0 114.051 153.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -108.25 77.34 0.23 Allowed Glycine 0 N--CA 1.498 2.796 0 N-CA-C 118.293 2.077 . . . . 0.0 118.293 -169.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.643 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 12.0 t80 -167.09 155.95 9.32 Favored Pre-proline 0 CA--C 1.589 2.461 0 C-N-CA 124.691 1.196 . . . . 0.0 109.915 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -36.06 -46.7 1.05 Allowed 'Trans proline' 0 CA--C 1.567 2.153 0 N-CA-C 122.378 3.953 . . . . 0.0 122.378 172.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.4 mp -86.06 -4.71 59.23 Favored 'General case' 0 CA--C 1.578 2.029 0 N-CA-C 116.083 1.883 . . . . 0.0 116.083 177.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.643 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 95.5 m -75.72 149.37 38.07 Favored 'General case' 0 CA--C 1.564 1.495 0 N-CA-C 117.43 2.381 . . . . 0.0 117.43 -163.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 34.3 p80 . . . . . 0 CA--C 1.581 2.148 0 N-CA-C 114.927 1.454 . . . . 0.0 114.927 -179.057 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.303 24.6 t . . . . . 0 N--CA 1.492 1.659 0 N-CA-C 111.205 0.076 . . . . 0.0 111.205 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.42 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 18.0 p -146.68 -147.49 0.22 Allowed 'General case' 0 CA--C 1.573 1.86 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -160.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 5.8 t -89.18 -49.01 7.0 Favored 'General case' 0 CA--C 1.574 1.878 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 155.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -120.61 72.46 0.35 Allowed Glycine 0 N--CA 1.495 2.619 0 N-CA-C 118.073 1.989 . . . . 0.0 118.073 -166.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.557 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 2.5 t80 -165.14 157.75 13.68 Favored Pre-proline 0 CA--C 1.591 2.54 0 C-N-CA 124.776 1.23 . . . . 0.0 109.132 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -35.75 -49.89 1.03 Allowed 'Trans proline' 0 CA--C 1.566 2.097 0 N-CA-C 122.001 3.808 . . . . 0.0 122.001 172.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 9.1 mp -76.79 -14.56 59.91 Favored 'General case' 0 CA--C 1.579 2.07 0 N-CA-C 116.401 2.001 . . . . 0.0 116.401 175.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.557 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 97.6 m -69.16 148.47 49.88 Favored 'General case' 0 CA--C 1.567 1.631 0 N-CA-C 118.007 2.595 . . . . 0.0 118.007 -162.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 34.0 p80 . . . . . 0 CA--C 1.581 2.172 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 176.633 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.317 72.2 t . . . . . 0 CA--C 1.569 1.688 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 20.3 p -137.19 -147.07 0.23 Allowed 'General case' 0 CA--C 1.574 1.9 0 C-N-CA 124.463 1.105 . . . . 0.0 113.861 -162.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 45.7 t -112.61 118.98 36.57 Favored 'General case' 0 CA--C 1.57 1.724 0 O-C-N 120.248 -1.532 . . . . 0.0 110.577 151.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 100.42 64.74 0.8 Allowed Glycine 0 N--CA 1.499 2.895 0 N-CA-C 117.811 1.884 . . . . 0.0 117.811 169.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.651 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 22.6 t80 -179.15 151.1 0.64 Allowed Pre-proline 0 CA--C 1.588 2.419 0 C-N-CA 125.272 1.429 . . . . 0.0 108.66 -172.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -34.45 -58.94 0.34 Allowed 'Trans proline' 0 CA--C 1.568 2.221 0 C-N-CA 124.593 3.529 . . . . 0.0 120.931 172.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.8 mp -78.45 -9.48 59.32 Favored 'General case' 0 CA--C 1.583 2.214 0 N-CA-C 116.232 1.938 . . . . 0.0 116.232 177.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.651 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 68.3 m -71.42 151.69 43.79 Favored 'General case' 0 CA--C 1.563 1.475 0 N-CA-C 116.774 2.138 . . . . 0.0 116.774 -169.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 29.4 p80 . . . . . 0 CA--C 1.581 2.143 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -179.015 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.303 31.9 t . . . . . 0 N--CA 1.494 1.727 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.441 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 16.8 p -147.64 -158.11 0.88 Allowed 'General case' 0 CA--C 1.576 1.962 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 -162.178 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 29.3 t -104.95 98.06 7.83 Favored 'General case' 0 CA--C 1.574 1.887 0 O-C-N 120.635 -1.29 . . . . 0.0 111.523 147.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 113.81 69.09 0.5 Allowed Glycine 0 N--CA 1.501 2.996 0 N-CA-C 117.692 1.837 . . . . 0.0 117.692 170.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.567 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 1.4 t80 -175.81 154.69 1.51 Allowed Pre-proline 0 CA--C 1.589 2.47 0 C-N-CA 125.612 1.565 . . . . 0.0 108.144 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -32.85 -51.75 0.4 Allowed 'Trans proline' 0 CA--C 1.569 2.237 0 N-CA-C 121.898 3.768 . . . . 0.0 121.898 173.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.9 mp -84.71 -0.64 54.31 Favored 'General case' 0 CA--C 1.582 2.187 0 N-CA-C 116.213 1.931 . . . . 0.0 116.213 177.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.567 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 92.3 m -77.88 146.43 35.63 Favored 'General case' 0 CA--C 1.564 1.503 0 O-C-N 119.478 -2.014 . . . . 0.0 116.383 -165.081 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 21.2 p80 . . . . . 0 CA--C 1.579 2.075 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 175.31 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.265 55.4 t . . . . . 0 N--CA 1.495 1.807 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.471 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 19.5 p -159.42 -159.47 0.75 Allowed 'General case' 0 CA--C 1.575 1.936 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -161.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 53.4 t -100.26 132.44 45.62 Favored 'General case' 0 CA--C 1.575 1.932 0 O-C-N 120.307 -1.496 . . . . 0.0 112.224 142.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 93.22 57.32 1.38 Allowed Glycine 0 N--CA 1.499 2.899 0 N-CA-C 118.155 2.022 . . . . 0.0 118.155 165.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.647 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 26.2 t80 -173.44 155.88 2.75 Favored Pre-proline 0 CA--C 1.584 2.257 0 CA-C-N 118.597 1.198 . . . . 0.0 110.682 -170.078 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -36.27 -56.98 0.61 Allowed 'Trans proline' 0 CA--C 1.568 2.182 0 N-CA-C 121.076 3.452 . . . . 0.0 121.076 171.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.3 mp -82.47 -6.43 59.3 Favored 'General case' 0 CA--C 1.58 2.115 0 N-CA-C 116.765 2.135 . . . . 0.0 116.765 178.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.647 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 74.3 m -75.39 150.69 38.3 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 116.796 2.147 . . . . 0.0 116.796 -165.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 23.9 p80 . . . . . 0 CA--C 1.579 2.07 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 179.886 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.297 55.4 t . . . . . 0 CA--C 1.572 1.79 0 N-CA-C 111.355 0.132 . . . . 0.0 111.355 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 17.1 p -148.18 -148.91 0.27 Allowed 'General case' 0 CA--C 1.578 2.031 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 -163.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 41.2 t -124.52 66.42 1.08 Allowed 'General case' 0 CA--C 1.579 2.095 0 O-C-N 120.793 -1.192 . . . . 0.0 112.366 160.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 150.02 61.13 0.01 OUTLIER Glycine 0 N--CA 1.502 3.063 0 N-CA-C 117.393 1.717 . . . . 0.0 117.393 177.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.611 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 3.6 t80 -172.7 153.57 2.74 Favored Pre-proline 0 CA--C 1.588 2.41 0 C-N-CA 125.137 1.375 . . . . 0.0 109.094 -176.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -33.53 -54.86 0.44 Allowed 'Trans proline' 0 CA--C 1.564 2.021 0 N-CA-C 121.971 3.797 . . . . 0.0 121.971 173.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.8 mp -81.0 -10.44 59.71 Favored 'General case' 0 CA--C 1.577 2.018 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 176.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.611 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 93.7 m -67.01 138.63 57.36 Favored 'General case' 0 CA--C 1.56 1.345 0 N-CA-C 115.987 1.847 . . . . 0.0 115.987 -168.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 18.6 p80 . . . . . 0 CA--C 1.577 2.003 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 -179.039 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.331 41.8 t . . . . . 0 CA--C 1.573 1.828 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.472 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 17.7 p -139.61 -148.94 0.27 Allowed 'General case' 0 CA--C 1.576 1.957 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -160.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 38.1 t -121.42 84.87 2.31 Favored 'General case' 0 CA--C 1.572 1.821 0 O-C-N 120.36 -1.462 . . . . 0.0 112.075 148.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 145.54 42.82 0.04 OUTLIER Glycine 0 N--CA 1.503 3.137 0 N-CA-C 118.631 2.212 . . . . 0.0 118.631 176.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.572 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 1.2 t80 -161.96 152.63 14.71 Favored Pre-proline 0 CA--C 1.58 2.106 0 CA-C-N 118.712 1.256 . . . . 0.0 109.121 -174.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -30.5 -55.94 0.2 Allowed 'Trans proline' 0 CA--C 1.569 2.238 0 N-CA-C 121.594 3.651 . . . . 0.0 121.594 174.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.6 mp -79.62 -7.8 58.77 Favored 'General case' 0 CA--C 1.579 2.058 0 N-CA-C 116.628 2.085 . . . . 0.0 116.628 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.572 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 96.7 m -68.0 145.15 54.76 Favored 'General case' 0 CA--C 1.568 1.664 0 N-CA-C 117.564 2.431 . . . . 0.0 117.564 -161.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 27.1 p80 -74.72 161.82 29.29 Favored 'General case' 0 CA--C 1.584 2.265 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 -175.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 34.6 m . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 124.387 2.042 . . . . 0.0 114.208 -168.393 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.303 20.1 t . . . . . 0 CA--C 1.569 1.678 0 N-CA-C 111.122 0.045 . . . . 0.0 111.122 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.477 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 17.1 p -144.13 -152.23 0.41 Allowed 'General case' 0 CA--C 1.575 1.921 0 N-CA-C 115.688 1.736 . . . . 0.0 115.688 -161.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 36.8 t -118.87 83.65 2.06 Favored 'General case' 0 CA--C 1.575 1.941 0 O-C-N 120.317 -1.49 . . . . 0.0 111.862 146.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 147.96 40.13 0.04 OUTLIER Glycine 0 N--CA 1.5 2.939 0 N-CA-C 119.83 2.692 . . . . 0.0 119.83 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.599 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 0.7 OUTLIER -162.04 155.63 17.95 Favored Pre-proline 0 CA--C 1.581 2.138 0 CA-C-N 119.445 1.623 . . . . 0.0 109.271 -175.918 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -31.16 -62.35 0.12 Allowed 'Trans proline' 0 CA--C 1.568 2.217 0 C-N-CA 124.272 3.315 . . . . 0.0 120.685 173.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.5 mp -73.62 -8.78 57.32 Favored 'General case' 0 CA--C 1.577 1.989 0 N-CA-C 117.477 2.399 . . . . 0.0 117.477 178.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.599 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 82.4 m -59.88 137.55 58.04 Favored 'General case' 0 CA--C 1.566 1.561 0 N-CA-C 117.529 2.418 . . . . 0.0 117.529 -161.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 30.2 p80 -68.53 160.7 29.39 Favored 'General case' 0 CA--C 1.578 2.04 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 -176.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 57.2 m . . . . . 0 CA--C 1.561 1.369 0 CA-C-O 124.72 2.2 . . . . 0.0 115.15 -174.424 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.262 35.8 t . . . . . 0 N--CA 1.493 1.694 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.431 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 20.9 p -159.96 -155.35 0.44 Allowed 'General case' 0 CA--C 1.575 1.938 0 C-N-CA 124.041 0.937 . . . . 0.0 113.315 -161.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 51.9 t -113.3 113.42 25.24 Favored 'General case' 0 CA--C 1.573 1.862 0 O-C-N 120.751 -1.218 . . . . 0.0 111.425 151.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 109.39 62.86 0.53 Allowed Glycine 0 N--CA 1.5 2.955 0 N-CA-C 118.353 2.101 . . . . 0.0 118.353 169.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.686 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 66.8 t80 -178.21 151.16 0.77 Allowed Pre-proline 0 CA--C 1.582 2.175 0 C-N-CA 125.224 1.409 . . . . 0.0 108.167 -167.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -32.78 -54.26 0.37 Allowed 'Trans proline' 0 CA--C 1.568 2.195 0 N-CA-C 121.418 3.584 . . . . 0.0 121.418 169.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.8 mp -84.84 2.17 43.65 Favored 'General case' 0 CA--C 1.58 2.117 0 N-CA-C 116.213 1.931 . . . . 0.0 116.213 177.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.686 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 93.7 m -92.16 129.22 38.16 Favored 'General case' 0 CA--C 1.562 1.434 0 O-C-N 119.882 -1.761 . . . . 0.0 114.248 -169.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 20.7 p80 -73.95 167.79 20.77 Favored 'General case' 0 CA--C 1.581 2.145 0 N-CA-C 117.425 2.38 . . . . 0.0 117.425 -173.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 57.7 m . . . . . 0 N--CA 1.483 1.18 0 CA-C-O 124.228 1.966 . . . . 0.0 114.027 -164.438 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.299 56.1 t . . . . . 0 N--CA 1.494 1.748 0 CA-C-O 119.696 -0.192 . . . . 0.0 110.734 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 17.8 p -147.5 -152.79 0.45 Allowed 'General case' 0 CA--C 1.578 2.035 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -165.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 52.8 t -119.08 73.8 0.95 Allowed 'General case' 0 CA--C 1.576 1.979 0 O-C-N 120.521 -1.362 . . . . 0.0 112.626 154.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 152.6 57.29 0.01 OUTLIER Glycine 0 N--CA 1.502 3.08 0 N-CA-C 118.532 2.173 . . . . 0.0 118.532 173.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.572 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 5.5 t80 -174.65 155.25 2.01 Favored Pre-proline 0 CA--C 1.591 2.539 0 C-N-CA 125.16 1.384 . . . . 0.0 109.694 -172.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -37.33 -55.82 0.92 Allowed 'Trans proline' 0 CA--C 1.57 2.319 0 N-CA-C 121.62 3.662 . . . . 0.0 121.62 173.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.6 mp -78.01 -8.97 58.87 Favored 'General case' 0 CA--C 1.581 2.136 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 175.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.572 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 79.9 m -70.9 135.41 47.97 Favored 'General case' 0 CA--C 1.564 1.508 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 -177.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 33.9 p80 -76.99 162.88 27.21 Favored 'General case' 0 CA--C 1.578 2.036 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -177.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 17.0 m . . . . . 0 N--CA 1.484 1.27 0 CA-C-O 124.062 1.887 . . . . 0.0 112.708 -163.283 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.283 54.8 t . . . . . 0 CA--C 1.571 1.762 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.458 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 17.9 p -153.6 -162.66 1.49 Allowed 'General case' 0 CA--C 1.575 1.921 0 N-CA-C 115.216 1.561 . . . . 0.0 115.216 -161.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 44.4 t -101.18 107.57 19.01 Favored 'General case' 0 CA--C 1.573 1.856 0 O-C-N 120.462 -1.399 . . . . 0.0 111.426 146.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 114.1 59.04 0.38 Allowed Glycine 0 N--CA 1.5 2.922 0 N-CA-C 118.101 2.0 . . . . 0.0 118.101 165.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.647 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 8.3 t80 -171.39 154.96 4.04 Favored Pre-proline 0 CA--C 1.586 2.35 0 CA-C-N 118.684 1.242 . . . . 0.0 110.75 -174.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -35.86 -53.04 0.94 Allowed 'Trans proline' 0 CA--C 1.568 2.198 0 N-CA-C 122.159 3.869 . . . . 0.0 122.159 173.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.6 mp -81.89 -13.4 57.62 Favored 'General case' 0 CA--C 1.58 2.099 0 N-CA-C 115.81 1.781 . . . . 0.0 115.81 176.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.647 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 98.6 m -68.87 148.84 49.65 Favored 'General case' 0 CA--C 1.562 1.436 0 N-CA-C 116.8 2.148 . . . . 0.0 116.8 -168.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 24.3 p80 -78.29 163.9 25.34 Favored 'General case' 0 CA--C 1.58 2.111 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 176.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 83.1 m . . . . . 0 N--CA 1.485 1.295 0 CA-C-O 125.214 2.435 . . . . 0.0 113.348 -170.186 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 23.4 t . . . . . 0 N--CA 1.496 1.856 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.469 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 20.6 p -163.25 -162.8 0.78 Allowed 'General case' 0 CA--C 1.58 2.113 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -161.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 51.1 t -100.67 115.6 30.6 Favored 'General case' 0 CA--C 1.572 1.824 0 O-C-N 120.116 -1.615 . . . . 0.0 112.424 139.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 118.95 47.58 0.39 Allowed Glycine 0 N--CA 1.506 3.326 0 N-CA-C 119.77 2.668 . . . . 0.0 119.77 165.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.663 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 33.1 t80 -170.66 152.77 3.93 Favored Pre-proline 0 CA--C 1.585 2.306 0 CA-C-N 118.869 1.334 . . . . 0.0 110.39 -167.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -33.01 -56.81 0.33 Allowed 'Trans proline' 0 CA--C 1.568 2.199 0 N-CA-C 121.317 3.545 . . . . 0.0 121.317 172.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.3 mp -78.26 -11.25 59.92 Favored 'General case' 0 CA--C 1.58 2.121 0 N-CA-C 116.867 2.173 . . . . 0.0 116.867 178.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.663 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 86.4 m -73.37 155.12 39.7 Favored 'General case' 0 CA--C 1.565 1.543 0 N-CA-C 116.544 2.053 . . . . 0.0 116.544 -170.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 27.4 p80 -90.2 166.06 13.58 Favored 'General case' 0 CA--C 1.579 2.09 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 -178.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 53.8 m . . . . . 0 CA--C 1.56 1.361 0 CA-C-O 125.408 2.528 . . . . 0.0 112.85 -165.683 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.325 45.3 t . . . . . 0 CA--C 1.571 1.787 0 CA-C-O 119.872 -0.109 . . . . 0.0 111.004 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 19.2 p -146.3 -155.67 0.64 Allowed 'General case' 0 CA--C 1.578 2.057 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 -160.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 43.2 t -113.58 99.93 8.11 Favored 'General case' 0 CA--C 1.57 1.736 0 O-C-N 120.061 -1.649 . . . . 0.0 110.525 139.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 138.56 33.82 0.18 Allowed Glycine 0 N--CA 1.501 3.019 0 N-CA-C 120.157 2.823 . . . . 0.0 120.157 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.58 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 11.0 t80 -163.23 155.07 15.14 Favored Pre-proline 0 CA--C 1.582 2.186 0 CA-C-N 119.002 1.401 . . . . 0.0 109.299 -178.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -34.74 -61.02 0.26 Allowed 'Trans proline' 0 CA--C 1.568 2.18 0 C-N-CA 124.381 3.387 . . . . 0.0 120.767 172.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.1 mp -73.29 -0.24 13.97 Favored 'General case' 0 CA--C 1.583 2.224 0 N-CA-C 117.282 2.327 . . . . 0.0 117.282 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.58 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 95.7 m -70.31 151.56 45.14 Favored 'General case' 0 CA--C 1.563 1.463 0 N-CA-C 116.514 2.042 . . . . 0.0 116.514 -171.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 16.5 p80 -83.89 161.49 20.84 Favored 'General case' 0 CA--C 1.579 2.096 0 N-CA-C 114.409 1.262 . . . . 0.0 114.409 176.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 79.8 m . . . . . 0 N--CA 1.482 1.146 0 CA-C-O 124.604 2.145 . . . . 0.0 114.016 -169.171 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.428 ' HB ' ' SG ' ' A' ' 8' ' ' CYS 0.297 53.4 t . . . . . 0 CA--C 1.572 1.8 0 N-CA-C 111.593 0.22 . . . . 0.0 111.593 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.414 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 20.3 p -156.77 -148.48 0.22 Allowed 'General case' 0 CA--C 1.581 2.171 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -161.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 15.5 t -112.09 122.99 49.29 Favored 'General case' 0 CA--C 1.573 1.862 0 O-C-N 120.353 -1.467 . . . . 0.0 111.863 155.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 97.47 60.38 0.95 Allowed Glycine 0 N--CA 1.502 3.086 0 N-CA-C 118.34 2.096 . . . . 0.0 118.34 166.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.639 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 53.0 t80 -177.81 151.05 0.82 Allowed Pre-proline 0 CA--C 1.586 2.356 0 C-N-CA 124.882 1.273 . . . . 0.0 109.192 -163.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -36.8 -63.32 0.22 Allowed 'Trans proline' 0 CA--C 1.57 2.277 0 C-N-CA 124.427 3.418 . . . . 0.0 120.34 173.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.4 mp -74.84 -15.96 60.71 Favored 'General case' 0 CA--C 1.579 2.069 0 N-CA-C 116.326 1.973 . . . . 0.0 116.326 176.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.639 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 91.4 m -71.92 141.19 49.48 Favored 'General case' 0 CA--C 1.558 1.285 0 N-CA-C 115.181 1.548 . . . . 0.0 115.181 -174.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 15.1 p80 -73.08 155.8 39.37 Favored 'General case' 0 CA--C 1.577 2.016 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 37.3 m . . . . . 0 CA--C 1.56 1.334 0 CA-C-O 124.883 2.278 . . . . 0.0 112.785 -170.653 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.277 53.6 t . . . . . 0 N--CA 1.494 1.757 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.514 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 19.3 p -152.24 -155.92 0.66 Allowed 'General case' 0 CA--C 1.574 1.867 0 C-N-CA 124.423 1.089 . . . . 0.0 113.033 -165.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 14.8 t -80.69 -54.86 5.26 Favored 'General case' 0 CA--C 1.574 1.904 0 N-CA-C 116.263 1.949 . . . . 0.0 116.263 160.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -127.37 85.94 0.33 Allowed Glycine 0 N--CA 1.495 2.581 0 CA-C-N 120.69 1.586 . . . . 0.0 115.936 -165.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.671 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 16.6 t80 -170.82 155.09 4.56 Favored Pre-proline 0 CA--C 1.583 2.241 0 C-N-CA 124.718 1.207 . . . . 0.0 110.004 -173.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -33.89 -48.94 0.54 Allowed 'Trans proline' 0 CA--C 1.566 2.116 0 N-CA-C 121.962 3.793 . . . . 0.0 121.962 173.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 8.3 mp -86.86 -13.1 45.9 Favored 'General case' 0 CA--C 1.578 2.048 0 N-CA-C 116.617 2.081 . . . . 0.0 116.617 178.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.671 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 66.3 m -70.16 166.03 20.81 Favored 'General case' 0 CA--C 1.565 1.536 0 N-CA-C 118.003 2.594 . . . . 0.0 118.003 -162.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 27.3 p80 -86.57 163.65 17.33 Favored 'General case' 0 CA--C 1.579 2.064 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 -178.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 72.5 m . . . . . 0 CA--C 1.562 1.44 0 CA-C-O 124.633 2.159 . . . . 0.0 115.503 -168.899 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.292 73.5 t . . . . . 0 N--CA 1.493 1.693 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.475 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 17.0 p -147.45 -151.2 0.37 Allowed 'General case' 0 CA--C 1.575 1.933 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -161.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 11.9 t -87.51 -45.19 10.7 Favored 'General case' 0 CA--C 1.576 1.959 0 N-CA-C 115.877 1.806 . . . . 0.0 115.877 154.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -123.73 75.12 0.38 Allowed Glycine 0 N--CA 1.495 2.63 0 N-CA-C 117.253 1.661 . . . . 0.0 117.253 -167.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.607 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 2.3 t80 -167.62 152.64 6.77 Favored Pre-proline 0 CA--C 1.584 2.262 0 C-N-CA 124.939 1.296 . . . . 0.0 108.956 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -31.0 -54.69 0.24 Allowed 'Trans proline' 0 CA--C 1.569 2.274 0 N-CA-C 122.38 3.954 . . . . 0.0 122.38 173.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.1 mp -85.19 4.8 32.88 Favored 'General case' 0 CA--C 1.585 2.325 0 N-CA-C 116.682 2.104 . . . . 0.0 116.682 178.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.607 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 82.3 m -77.09 144.72 38.31 Favored 'General case' 0 CA--C 1.562 1.441 0 O-C-N 119.602 -1.936 . . . . 0.0 116.012 -167.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 35.5 p80 -66.92 166.05 14.25 Favored 'General case' 0 CA--C 1.584 2.261 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 171.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 76.3 m . . . . . 0 CA--C 1.56 1.362 0 CA-C-O 124.62 2.153 . . . . 0.0 114.375 -173.605 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.281 40.7 t . . . . . 0 N--CA 1.496 1.838 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.502 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 17.6 p -150.94 -147.32 0.23 Allowed 'General case' 0 CA--C 1.575 1.935 0 C-N-CA 124.116 0.966 . . . . 0.0 113.523 -164.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 20.8 t -93.79 -56.46 2.88 Favored 'General case' 0 CA--C 1.577 2.007 0 O-C-N 120.733 -1.23 . . . . 0.0 114.051 153.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -108.25 77.34 0.23 Allowed Glycine 0 N--CA 1.498 2.796 0 N-CA-C 118.293 2.077 . . . . 0.0 118.293 -169.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.643 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 12.0 t80 -167.09 155.95 9.32 Favored Pre-proline 0 CA--C 1.589 2.461 0 C-N-CA 124.691 1.196 . . . . 0.0 109.915 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -36.06 -46.7 1.05 Allowed 'Trans proline' 0 CA--C 1.567 2.153 0 N-CA-C 122.378 3.953 . . . . 0.0 122.378 172.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.4 mp -86.06 -4.71 59.23 Favored 'General case' 0 CA--C 1.578 2.029 0 N-CA-C 116.083 1.883 . . . . 0.0 116.083 177.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.643 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 95.5 m -75.72 149.37 38.07 Favored 'General case' 0 CA--C 1.564 1.495 0 N-CA-C 117.43 2.381 . . . . 0.0 117.43 -163.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 34.3 p80 -81.55 172.36 13.57 Favored 'General case' 0 CA--C 1.581 2.148 0 N-CA-C 114.927 1.454 . . . . 0.0 114.927 -179.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 86.5 m . . . . . 0 N--CA 1.484 1.258 0 CA-C-O 125.358 2.504 . . . . 0.0 116.234 -166.372 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.303 24.6 t . . . . . 0 N--CA 1.492 1.659 0 N-CA-C 111.205 0.076 . . . . 0.0 111.205 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.42 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 18.0 p -146.68 -147.49 0.22 Allowed 'General case' 0 CA--C 1.573 1.86 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -160.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 5.8 t -89.18 -49.01 7.0 Favored 'General case' 0 CA--C 1.574 1.878 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 155.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -120.61 72.46 0.35 Allowed Glycine 0 N--CA 1.495 2.619 0 N-CA-C 118.073 1.989 . . . . 0.0 118.073 -166.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.557 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 2.5 t80 -165.14 157.75 13.68 Favored Pre-proline 0 CA--C 1.591 2.54 0 C-N-CA 124.776 1.23 . . . . 0.0 109.132 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -35.75 -49.89 1.03 Allowed 'Trans proline' 0 CA--C 1.566 2.097 0 N-CA-C 122.001 3.808 . . . . 0.0 122.001 172.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 9.1 mp -76.79 -14.56 59.91 Favored 'General case' 0 CA--C 1.579 2.07 0 N-CA-C 116.401 2.001 . . . . 0.0 116.401 175.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.557 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 97.6 m -69.16 148.47 49.88 Favored 'General case' 0 CA--C 1.567 1.631 0 N-CA-C 118.007 2.595 . . . . 0.0 118.007 -162.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 34.0 p80 -83.81 171.01 13.53 Favored 'General case' 0 CA--C 1.581 2.172 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 176.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 77.7 m . . . . . 0 N--CA 1.481 1.082 0 CA-C-O 124.392 2.044 . . . . 0.0 112.71 -172.397 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.317 72.2 t . . . . . 0 CA--C 1.569 1.688 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 20.3 p -137.19 -147.07 0.23 Allowed 'General case' 0 CA--C 1.574 1.9 0 C-N-CA 124.463 1.105 . . . . 0.0 113.861 -162.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 45.7 t -112.61 118.98 36.57 Favored 'General case' 0 CA--C 1.57 1.724 0 O-C-N 120.248 -1.532 . . . . 0.0 110.577 151.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 100.42 64.74 0.8 Allowed Glycine 0 N--CA 1.499 2.895 0 N-CA-C 117.811 1.884 . . . . 0.0 117.811 169.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.651 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 22.6 t80 -179.15 151.1 0.64 Allowed Pre-proline 0 CA--C 1.588 2.419 0 C-N-CA 125.272 1.429 . . . . 0.0 108.66 -172.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -34.45 -58.94 0.34 Allowed 'Trans proline' 0 CA--C 1.568 2.221 0 C-N-CA 124.593 3.529 . . . . 0.0 120.931 172.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.8 mp -78.45 -9.48 59.32 Favored 'General case' 0 CA--C 1.583 2.214 0 N-CA-C 116.232 1.938 . . . . 0.0 116.232 177.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.651 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 68.3 m -71.42 151.69 43.79 Favored 'General case' 0 CA--C 1.563 1.475 0 N-CA-C 116.774 2.138 . . . . 0.0 116.774 -169.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 29.4 p80 -88.85 165.38 14.69 Favored 'General case' 0 CA--C 1.581 2.143 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -179.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 51.3 m . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 124.918 2.294 . . . . 0.0 114.622 -162.597 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.303 31.9 t . . . . . 0 N--CA 1.494 1.727 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.441 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 16.8 p -147.64 -158.11 0.88 Allowed 'General case' 0 CA--C 1.576 1.962 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 -162.178 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 29.3 t -104.95 98.06 7.83 Favored 'General case' 0 CA--C 1.574 1.887 0 O-C-N 120.635 -1.29 . . . . 0.0 111.523 147.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 113.81 69.09 0.5 Allowed Glycine 0 N--CA 1.501 2.996 0 N-CA-C 117.692 1.837 . . . . 0.0 117.692 170.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.567 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 1.4 t80 -175.81 154.69 1.51 Allowed Pre-proline 0 CA--C 1.589 2.47 0 C-N-CA 125.612 1.565 . . . . 0.0 108.144 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -32.85 -51.75 0.4 Allowed 'Trans proline' 0 CA--C 1.569 2.237 0 N-CA-C 121.898 3.768 . . . . 0.0 121.898 173.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.9 mp -84.71 -0.64 54.31 Favored 'General case' 0 CA--C 1.582 2.187 0 N-CA-C 116.213 1.931 . . . . 0.0 116.213 177.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.567 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 92.3 m -77.88 146.43 35.63 Favored 'General case' 0 CA--C 1.564 1.503 0 O-C-N 119.478 -2.014 . . . . 0.0 116.383 -165.081 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 21.2 p80 -80.21 161.0 25.42 Favored 'General case' 0 CA--C 1.579 2.075 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 175.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 73.1 m . . . . . 0 N--CA 1.483 1.207 0 CA-C-O 125.441 2.543 . . . . 0.0 116.008 -166.189 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.265 55.4 t . . . . . 0 N--CA 1.495 1.807 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.471 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 19.5 p -159.42 -159.47 0.75 Allowed 'General case' 0 CA--C 1.575 1.936 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -161.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 53.4 t -100.26 132.44 45.62 Favored 'General case' 0 CA--C 1.575 1.932 0 O-C-N 120.307 -1.496 . . . . 0.0 112.224 142.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 93.22 57.32 1.38 Allowed Glycine 0 N--CA 1.499 2.899 0 N-CA-C 118.155 2.022 . . . . 0.0 118.155 165.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.647 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 26.2 t80 -173.44 155.88 2.75 Favored Pre-proline 0 CA--C 1.584 2.257 0 CA-C-N 118.597 1.198 . . . . 0.0 110.682 -170.078 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -36.27 -56.98 0.61 Allowed 'Trans proline' 0 CA--C 1.568 2.182 0 N-CA-C 121.076 3.452 . . . . 0.0 121.076 171.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.3 mp -82.47 -6.43 59.3 Favored 'General case' 0 CA--C 1.58 2.115 0 N-CA-C 116.765 2.135 . . . . 0.0 116.765 178.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.647 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 74.3 m -75.39 150.69 38.3 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 116.796 2.147 . . . . 0.0 116.796 -165.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 23.9 p80 -81.92 166.27 20.03 Favored 'General case' 0 CA--C 1.579 2.07 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 59.8 m . . . . . 0 N--CA 1.483 1.187 0 CA-C-O 125.171 2.415 . . . . 0.0 112.381 -169.975 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.297 55.4 t . . . . . 0 CA--C 1.572 1.79 0 N-CA-C 111.355 0.132 . . . . 0.0 111.355 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 17.1 p -148.18 -148.91 0.27 Allowed 'General case' 0 CA--C 1.578 2.031 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 -163.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 41.2 t -124.52 66.42 1.08 Allowed 'General case' 0 CA--C 1.579 2.095 0 O-C-N 120.793 -1.192 . . . . 0.0 112.366 160.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 150.02 61.13 0.01 OUTLIER Glycine 0 N--CA 1.502 3.063 0 N-CA-C 117.393 1.717 . . . . 0.0 117.393 177.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.611 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 3.6 t80 -172.7 153.57 2.74 Favored Pre-proline 0 CA--C 1.588 2.41 0 C-N-CA 125.137 1.375 . . . . 0.0 109.094 -176.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -33.53 -54.86 0.44 Allowed 'Trans proline' 0 CA--C 1.564 2.021 0 N-CA-C 121.971 3.797 . . . . 0.0 121.971 173.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.8 mp -81.0 -10.44 59.71 Favored 'General case' 0 CA--C 1.577 2.018 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 176.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.611 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 93.7 m -67.01 138.63 57.36 Favored 'General case' 0 CA--C 1.56 1.345 0 N-CA-C 115.987 1.847 . . . . 0.0 115.987 -168.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 18.6 p80 -74.15 156.89 36.87 Favored 'General case' 0 CA--C 1.577 2.003 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 -179.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 11.0 m . . . . . 0 CA--C 1.562 1.428 0 CA-C-O 124.991 2.329 . . . . 0.0 112.943 -173.559 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.331 41.8 t . . . . . 0 CA--C 1.573 1.828 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.471 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 17.7 p -139.61 -148.94 0.27 Allowed 'General case' 0 CA--C 1.576 1.957 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -160.118 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 38.1 t -121.42 84.87 2.31 Favored 'General case' 0 CA--C 1.572 1.821 0 O-C-N 120.36 -1.462 . . . . 0.0 112.075 148.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 145.54 42.82 0.04 OUTLIER Glycine 0 N--CA 1.503 3.137 0 N-CA-C 118.631 2.212 . . . . 0.0 118.631 176.019 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.62 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 1.2 t80 -161.96 152.63 14.71 Favored Pre-proline 0 CA--C 1.58 2.106 0 CA-C-N 118.712 1.256 . . . . 0.0 109.121 -174.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -30.5 -55.94 0.2 Allowed 'Trans proline' 0 CA--C 1.569 2.238 0 N-CA-C 121.594 3.651 . . . . 0.0 121.594 174.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.6 mp -79.62 -7.8 58.77 Favored 'General case' 0 CA--C 1.579 2.058 0 N-CA-C 116.628 2.085 . . . . 0.0 116.628 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.62 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 96.7 m -68.0 145.15 54.76 Favored 'General case' 0 CA--C 1.568 1.664 0 N-CA-C 117.564 2.431 . . . . 0.0 117.564 -161.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 27.1 p80 . . . . . 0 CA--C 1.584 2.265 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 -175.259 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.303 20.1 t . . . . . 0 CA--C 1.569 1.678 0 N-CA-C 111.122 0.045 . . . . 0.0 111.122 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.475 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 17.1 p -144.13 -152.23 0.41 Allowed 'General case' 0 CA--C 1.575 1.921 0 N-CA-C 115.688 1.736 . . . . 0.0 115.688 -161.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 36.8 t -118.87 83.65 2.06 Favored 'General case' 0 CA--C 1.575 1.941 0 O-C-N 120.317 -1.49 . . . . 0.0 111.862 146.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 147.96 40.13 0.04 OUTLIER Glycine 0 N--CA 1.5 2.939 0 N-CA-C 119.83 2.692 . . . . 0.0 119.83 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.666 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 0.7 OUTLIER -162.04 155.63 17.95 Favored Pre-proline 0 CA--C 1.581 2.138 0 CA-C-N 119.445 1.623 . . . . 0.0 109.271 -175.918 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -31.16 -62.35 0.12 Allowed 'Trans proline' 0 CA--C 1.568 2.217 0 C-N-CA 124.272 3.315 . . . . 0.0 120.685 173.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.5 mp -73.62 -8.78 57.32 Favored 'General case' 0 CA--C 1.577 1.989 0 N-CA-C 117.477 2.399 . . . . 0.0 117.477 178.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.666 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 82.4 m -59.88 137.55 58.04 Favored 'General case' 0 CA--C 1.566 1.561 0 N-CA-C 117.529 2.418 . . . . 0.0 117.529 -161.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 30.2 p80 . . . . . 0 CA--C 1.578 2.04 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 -176.214 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.262 35.8 t . . . . . 0 N--CA 1.493 1.694 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.431 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 20.9 p -159.96 -155.35 0.44 Allowed 'General case' 0 CA--C 1.575 1.938 0 C-N-CA 124.041 0.937 . . . . 0.0 113.315 -161.377 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 51.9 t -113.3 113.42 25.24 Favored 'General case' 0 CA--C 1.573 1.862 0 O-C-N 120.751 -1.218 . . . . 0.0 111.425 151.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 109.39 62.86 0.53 Allowed Glycine 0 N--CA 1.5 2.955 0 N-CA-C 118.353 2.101 . . . . 0.0 118.353 169.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.694 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 66.8 t80 -178.21 151.16 0.77 Allowed Pre-proline 0 CA--C 1.582 2.175 0 C-N-CA 125.224 1.409 . . . . 0.0 108.167 -167.124 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -32.78 -54.26 0.37 Allowed 'Trans proline' 0 CA--C 1.568 2.195 0 N-CA-C 121.418 3.584 . . . . 0.0 121.418 169.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.8 mp -84.84 2.17 43.65 Favored 'General case' 0 CA--C 1.58 2.117 0 N-CA-C 116.213 1.931 . . . . 0.0 116.213 177.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.694 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 93.7 m -92.16 129.22 38.16 Favored 'General case' 0 CA--C 1.562 1.434 0 O-C-N 119.882 -1.761 . . . . 0.0 114.248 -169.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 20.7 p80 . . . . . 0 CA--C 1.581 2.145 0 N-CA-C 117.425 2.38 . . . . 0.0 117.425 -173.081 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.299 56.1 t . . . . . 0 N--CA 1.494 1.748 0 CA-C-O 119.696 -0.192 . . . . 0.0 110.734 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 17.8 p -147.5 -152.79 0.45 Allowed 'General case' 0 CA--C 1.578 2.035 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -165.362 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 52.8 t -119.08 73.8 0.95 Allowed 'General case' 0 CA--C 1.576 1.979 0 O-C-N 120.521 -1.362 . . . . 0.0 112.626 154.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 152.6 57.29 0.01 OUTLIER Glycine 0 N--CA 1.502 3.08 0 N-CA-C 118.532 2.173 . . . . 0.0 118.532 173.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.608 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 5.5 t80 -174.65 155.25 2.01 Favored Pre-proline 0 CA--C 1.591 2.539 0 C-N-CA 125.16 1.384 . . . . 0.0 109.694 -172.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -37.33 -55.82 0.92 Allowed 'Trans proline' 0 CA--C 1.57 2.319 0 N-CA-C 121.62 3.662 . . . . 0.0 121.62 173.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.6 mp -78.01 -8.97 58.87 Favored 'General case' 0 CA--C 1.581 2.136 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 175.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.608 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 79.9 m -70.9 135.41 47.97 Favored 'General case' 0 CA--C 1.564 1.508 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 -177.142 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 33.9 p80 . . . . . 0 CA--C 1.578 2.036 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -177.479 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' VAL . . . . . 0.403 ' HB ' ' SG ' ' A' ' 8' ' ' CYS 0.283 54.8 t . . . . . 0 CA--C 1.571 1.762 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.43 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 17.9 p -153.6 -162.66 1.49 Allowed 'General case' 0 CA--C 1.575 1.921 0 N-CA-C 115.216 1.561 . . . . 0.0 115.216 -161.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 44.4 t -101.18 107.57 19.01 Favored 'General case' 0 CA--C 1.573 1.856 0 O-C-N 120.462 -1.399 . . . . 0.0 111.426 146.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 114.1 59.04 0.38 Allowed Glycine 0 N--CA 1.5 2.922 0 N-CA-C 118.101 2.0 . . . . 0.0 118.101 165.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.682 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 8.3 t80 -171.39 154.96 4.04 Favored Pre-proline 0 CA--C 1.586 2.35 0 CA-C-N 118.684 1.242 . . . . 0.0 110.75 -174.092 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -35.86 -53.04 0.94 Allowed 'Trans proline' 0 CA--C 1.568 2.198 0 N-CA-C 122.159 3.869 . . . . 0.0 122.159 173.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.6 mp -81.89 -13.4 57.62 Favored 'General case' 0 CA--C 1.58 2.099 0 N-CA-C 115.81 1.781 . . . . 0.0 115.81 176.116 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.682 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 98.6 m -68.87 148.84 49.65 Favored 'General case' 0 CA--C 1.562 1.436 0 N-CA-C 116.8 2.148 . . . . 0.0 116.8 -168.526 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 24.3 p80 . . . . . 0 CA--C 1.58 2.111 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 176.303 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' VAL . . . . . 0.401 ' HB ' ' SG ' ' A' ' 8' ' ' CYS . 23.4 t . . . . . 0 N--CA 1.496 1.856 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.441 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 20.6 p -163.25 -162.8 0.78 Allowed 'General case' 0 CA--C 1.58 2.113 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -161.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 51.1 t -100.67 115.6 30.6 Favored 'General case' 0 CA--C 1.572 1.824 0 O-C-N 120.116 -1.615 . . . . 0.0 112.424 139.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 118.95 47.58 0.39 Allowed Glycine 0 N--CA 1.506 3.326 0 N-CA-C 119.77 2.668 . . . . 0.0 119.77 165.508 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.688 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 33.1 t80 -170.66 152.77 3.93 Favored Pre-proline 0 CA--C 1.585 2.306 0 CA-C-N 118.869 1.334 . . . . 0.0 110.39 -167.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -33.01 -56.81 0.33 Allowed 'Trans proline' 0 CA--C 1.568 2.199 0 N-CA-C 121.317 3.545 . . . . 0.0 121.317 172.344 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.3 mp -78.26 -11.25 59.92 Favored 'General case' 0 CA--C 1.58 2.121 0 N-CA-C 116.867 2.173 . . . . 0.0 116.867 178.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.688 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 86.4 m -73.37 155.12 39.7 Favored 'General case' 0 CA--C 1.565 1.543 0 N-CA-C 116.544 2.053 . . . . 0.0 116.544 -170.276 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 27.4 p80 . . . . . 0 CA--C 1.579 2.09 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 -178.464 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.325 45.3 t . . . . . 0 CA--C 1.571 1.787 0 CA-C-O 119.872 -0.109 . . . . 0.0 111.004 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 19.2 p -146.3 -155.67 0.64 Allowed 'General case' 0 CA--C 1.578 2.057 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 -160.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 43.2 t -113.58 99.93 8.11 Favored 'General case' 0 CA--C 1.57 1.736 0 O-C-N 120.061 -1.649 . . . . 0.0 110.525 139.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 138.56 33.82 0.18 Allowed Glycine 0 N--CA 1.501 3.019 0 N-CA-C 120.157 2.823 . . . . 0.0 120.157 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.641 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 11.0 t80 -163.23 155.07 15.14 Favored Pre-proline 0 CA--C 1.582 2.186 0 CA-C-N 119.002 1.401 . . . . 0.0 109.299 -178.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -34.74 -61.02 0.26 Allowed 'Trans proline' 0 CA--C 1.568 2.18 0 C-N-CA 124.381 3.387 . . . . 0.0 120.767 172.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.1 mp -73.29 -0.24 13.97 Favored 'General case' 0 CA--C 1.583 2.224 0 N-CA-C 117.282 2.327 . . . . 0.0 117.282 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.641 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 95.7 m -70.31 151.56 45.14 Favored 'General case' 0 CA--C 1.563 1.463 0 N-CA-C 116.514 2.042 . . . . 0.0 116.514 -171.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 16.5 p80 . . . . . 0 CA--C 1.579 2.096 0 N-CA-C 114.409 1.262 . . . . 0.0 114.409 176.687 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' VAL . . . . . 0.447 ' HB ' ' SG ' ' A' ' 8' ' ' CYS 0.297 53.4 t . . . . . 0 CA--C 1.572 1.8 0 N-CA-C 111.593 0.22 . . . . 0.0 111.593 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.414 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 20.3 p -156.77 -148.48 0.22 Allowed 'General case' 0 CA--C 1.581 2.171 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -161.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 15.5 t -112.09 122.99 49.29 Favored 'General case' 0 CA--C 1.573 1.862 0 O-C-N 120.353 -1.467 . . . . 0.0 111.863 155.082 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 97.47 60.38 0.95 Allowed Glycine 0 N--CA 1.502 3.086 0 N-CA-C 118.34 2.096 . . . . 0.0 118.34 166.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.661 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 53.0 t80 -177.81 151.05 0.82 Allowed Pre-proline 0 CA--C 1.586 2.356 0 C-N-CA 124.882 1.273 . . . . 0.0 109.192 -163.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -36.8 -63.32 0.22 Allowed 'Trans proline' 0 CA--C 1.57 2.277 0 C-N-CA 124.427 3.418 . . . . 0.0 120.34 173.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.4 mp -74.84 -15.96 60.71 Favored 'General case' 0 CA--C 1.579 2.069 0 N-CA-C 116.326 1.973 . . . . 0.0 116.326 176.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.661 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 91.4 m -71.92 141.19 49.48 Favored 'General case' 0 CA--C 1.558 1.285 0 N-CA-C 115.181 1.548 . . . . 0.0 115.181 -174.342 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 15.1 p80 . . . . . 0 CA--C 1.577 2.016 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 -179.532 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.277 53.6 t . . . . . 0 N--CA 1.494 1.757 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.492 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 19.3 p -152.24 -155.92 0.66 Allowed 'General case' 0 CA--C 1.574 1.867 0 C-N-CA 124.423 1.089 . . . . 0.0 113.033 -165.361 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 14.8 t -80.69 -54.86 5.26 Favored 'General case' 0 CA--C 1.574 1.904 0 N-CA-C 116.263 1.949 . . . . 0.0 116.263 160.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -127.37 85.94 0.33 Allowed Glycine 0 N--CA 1.495 2.581 0 CA-C-N 120.69 1.586 . . . . 0.0 115.936 -165.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.704 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 16.6 t80 -170.82 155.09 4.56 Favored Pre-proline 0 CA--C 1.583 2.241 0 C-N-CA 124.718 1.207 . . . . 0.0 110.004 -173.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -33.89 -48.94 0.54 Allowed 'Trans proline' 0 CA--C 1.566 2.116 0 N-CA-C 121.962 3.793 . . . . 0.0 121.962 173.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 8.3 mp -86.86 -13.1 45.9 Favored 'General case' 0 CA--C 1.578 2.048 0 N-CA-C 116.617 2.081 . . . . 0.0 116.617 178.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.704 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 66.3 m -70.16 166.03 20.81 Favored 'General case' 0 CA--C 1.565 1.536 0 N-CA-C 118.003 2.594 . . . . 0.0 118.003 -162.163 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 27.3 p80 . . . . . 0 CA--C 1.579 2.064 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 -178.085 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.292 73.5 t . . . . . 0 N--CA 1.493 1.693 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.47 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 17.0 p -147.45 -151.2 0.37 Allowed 'General case' 0 CA--C 1.575 1.933 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -161.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 11.9 t -87.51 -45.19 10.7 Favored 'General case' 0 CA--C 1.576 1.959 0 N-CA-C 115.877 1.806 . . . . 0.0 115.877 154.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -123.73 75.12 0.38 Allowed Glycine 0 N--CA 1.495 2.63 0 N-CA-C 117.253 1.661 . . . . 0.0 117.253 -167.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.649 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 2.3 t80 -167.62 152.64 6.77 Favored Pre-proline 0 CA--C 1.584 2.262 0 C-N-CA 124.939 1.296 . . . . 0.0 108.956 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -31.0 -54.69 0.24 Allowed 'Trans proline' 0 CA--C 1.569 2.274 0 N-CA-C 122.38 3.954 . . . . 0.0 122.38 173.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.1 mp -85.19 4.8 32.88 Favored 'General case' 0 CA--C 1.585 2.325 0 N-CA-C 116.682 2.104 . . . . 0.0 116.682 178.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.649 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 82.3 m -77.09 144.72 38.31 Favored 'General case' 0 CA--C 1.562 1.441 0 O-C-N 119.602 -1.936 . . . . 0.0 116.012 -167.538 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 35.5 p80 . . . . . 0 CA--C 1.584 2.261 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 171.924 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.281 40.7 t . . . . . 0 N--CA 1.496 1.838 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.479 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 17.6 p -150.94 -147.32 0.23 Allowed 'General case' 0 CA--C 1.575 1.935 0 C-N-CA 124.116 0.966 . . . . 0.0 113.523 -164.313 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 20.8 t -93.79 -56.46 2.88 Favored 'General case' 0 CA--C 1.577 2.007 0 O-C-N 120.733 -1.23 . . . . 0.0 114.051 153.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -108.25 77.34 0.23 Allowed Glycine 0 N--CA 1.498 2.796 0 N-CA-C 118.293 2.077 . . . . 0.0 118.293 -169.177 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.698 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 12.0 t80 -167.09 155.95 9.32 Favored Pre-proline 0 CA--C 1.589 2.461 0 C-N-CA 124.691 1.196 . . . . 0.0 109.915 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -36.06 -46.7 1.05 Allowed 'Trans proline' 0 CA--C 1.567 2.153 0 N-CA-C 122.378 3.953 . . . . 0.0 122.378 172.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.4 mp -86.06 -4.71 59.23 Favored 'General case' 0 CA--C 1.578 2.029 0 N-CA-C 116.083 1.883 . . . . 0.0 116.083 177.141 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.698 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 95.5 m -75.72 149.37 38.07 Favored 'General case' 0 CA--C 1.564 1.495 0 N-CA-C 117.43 2.381 . . . . 0.0 117.43 -163.03 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 34.3 p80 . . . . . 0 CA--C 1.581 2.148 0 N-CA-C 114.927 1.454 . . . . 0.0 114.927 -179.057 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.303 24.6 t . . . . . 0 N--CA 1.492 1.659 0 N-CA-C 111.205 0.076 . . . . 0.0 111.205 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.401 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 18.0 p -146.68 -147.49 0.22 Allowed 'General case' 0 CA--C 1.573 1.86 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -160.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 5.8 t -89.18 -49.01 7.0 Favored 'General case' 0 CA--C 1.574 1.878 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 155.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -120.61 72.46 0.35 Allowed Glycine 0 N--CA 1.495 2.619 0 N-CA-C 118.073 1.989 . . . . 0.0 118.073 -166.106 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.61 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 2.5 t80 -165.14 157.75 13.68 Favored Pre-proline 0 CA--C 1.591 2.54 0 C-N-CA 124.776 1.23 . . . . 0.0 109.132 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -35.75 -49.89 1.03 Allowed 'Trans proline' 0 CA--C 1.566 2.097 0 N-CA-C 122.001 3.808 . . . . 0.0 122.001 172.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 9.1 mp -76.79 -14.56 59.91 Favored 'General case' 0 CA--C 1.579 2.07 0 N-CA-C 116.401 2.001 . . . . 0.0 116.401 175.041 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.61 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 97.6 m -69.16 148.47 49.88 Favored 'General case' 0 CA--C 1.567 1.631 0 N-CA-C 118.007 2.595 . . . . 0.0 118.007 -162.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 34.0 p80 . . . . . 0 CA--C 1.581 2.172 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 176.633 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.317 72.2 t . . . . . 0 CA--C 1.569 1.688 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.419 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 20.3 p -137.19 -147.07 0.23 Allowed 'General case' 0 CA--C 1.574 1.9 0 C-N-CA 124.463 1.105 . . . . 0.0 113.861 -162.205 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 45.7 t -112.61 118.98 36.57 Favored 'General case' 0 CA--C 1.57 1.724 0 O-C-N 120.248 -1.532 . . . . 0.0 110.577 151.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 100.42 64.74 0.8 Allowed Glycine 0 N--CA 1.499 2.895 0 N-CA-C 117.811 1.884 . . . . 0.0 117.811 169.496 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.688 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 22.6 t80 -179.15 151.1 0.64 Allowed Pre-proline 0 CA--C 1.588 2.419 0 C-N-CA 125.272 1.429 . . . . 0.0 108.66 -172.333 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -34.45 -58.94 0.34 Allowed 'Trans proline' 0 CA--C 1.568 2.221 0 C-N-CA 124.593 3.529 . . . . 0.0 120.931 172.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.8 mp -78.45 -9.48 59.32 Favored 'General case' 0 CA--C 1.583 2.214 0 N-CA-C 116.232 1.938 . . . . 0.0 116.232 177.016 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.688 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 68.3 m -71.42 151.69 43.79 Favored 'General case' 0 CA--C 1.563 1.475 0 N-CA-C 116.774 2.138 . . . . 0.0 116.774 -169.532 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 29.4 p80 . . . . . 0 CA--C 1.581 2.143 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -179.015 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.303 31.9 t . . . . . 0 N--CA 1.494 1.727 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.425 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 16.8 p -147.64 -158.11 0.88 Allowed 'General case' 0 CA--C 1.576 1.962 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 -162.178 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 29.3 t -104.95 98.06 7.83 Favored 'General case' 0 CA--C 1.574 1.887 0 O-C-N 120.635 -1.29 . . . . 0.0 111.523 147.541 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 113.81 69.09 0.5 Allowed Glycine 0 N--CA 1.501 2.996 0 N-CA-C 117.692 1.837 . . . . 0.0 117.692 170.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.622 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 1.4 t80 -175.81 154.69 1.51 Allowed Pre-proline 0 CA--C 1.589 2.47 0 C-N-CA 125.612 1.565 . . . . 0.0 108.144 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -32.85 -51.75 0.4 Allowed 'Trans proline' 0 CA--C 1.569 2.237 0 N-CA-C 121.898 3.768 . . . . 0.0 121.898 173.103 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.9 mp -84.71 -0.64 54.31 Favored 'General case' 0 CA--C 1.582 2.187 0 N-CA-C 116.213 1.931 . . . . 0.0 116.213 177.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.622 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 92.3 m -77.88 146.43 35.63 Favored 'General case' 0 CA--C 1.564 1.503 0 O-C-N 119.478 -2.014 . . . . 0.0 116.383 -165.081 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 21.2 p80 . . . . . 0 CA--C 1.579 2.075 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 175.31 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' VAL . . . . . 0.43 ' HB ' ' SG ' ' A' ' 8' ' ' CYS 0.265 55.4 t . . . . . 0 N--CA 1.495 1.807 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.447 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 19.5 p -159.42 -159.47 0.75 Allowed 'General case' 0 CA--C 1.575 1.936 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -161.844 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 53.4 t -100.26 132.44 45.62 Favored 'General case' 0 CA--C 1.575 1.932 0 O-C-N 120.307 -1.496 . . . . 0.0 112.224 142.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 93.22 57.32 1.38 Allowed Glycine 0 N--CA 1.499 2.899 0 N-CA-C 118.155 2.022 . . . . 0.0 118.155 165.006 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.668 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 26.2 t80 -173.44 155.88 2.75 Favored Pre-proline 0 CA--C 1.584 2.257 0 CA-C-N 118.597 1.198 . . . . 0.0 110.682 -170.078 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -36.27 -56.98 0.61 Allowed 'Trans proline' 0 CA--C 1.568 2.182 0 N-CA-C 121.076 3.452 . . . . 0.0 121.076 171.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.3 mp -82.47 -6.43 59.3 Favored 'General case' 0 CA--C 1.58 2.115 0 N-CA-C 116.765 2.135 . . . . 0.0 116.765 178.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.668 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 74.3 m -75.39 150.69 38.3 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 116.796 2.147 . . . . 0.0 116.796 -165.772 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 23.9 p80 . . . . . 0 CA--C 1.579 2.07 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 179.886 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.297 55.4 t . . . . . 0 CA--C 1.572 1.79 0 N-CA-C 111.355 0.132 . . . . 0.0 111.355 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 17.1 p -148.18 -148.91 0.27 Allowed 'General case' 0 CA--C 1.578 2.031 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 -163.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 41.2 t -124.52 66.42 1.08 Allowed 'General case' 0 CA--C 1.579 2.095 0 O-C-N 120.793 -1.192 . . . . 0.0 112.366 160.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 150.02 61.13 0.01 OUTLIER Glycine 0 N--CA 1.502 3.063 0 N-CA-C 117.393 1.717 . . . . 0.0 117.393 177.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.66 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 3.6 t80 -172.7 153.57 2.74 Favored Pre-proline 0 CA--C 1.588 2.41 0 C-N-CA 125.137 1.375 . . . . 0.0 109.094 -176.276 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -33.53 -54.86 0.44 Allowed 'Trans proline' 0 CA--C 1.564 2.021 0 N-CA-C 121.971 3.797 . . . . 0.0 121.971 173.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.8 mp -81.0 -10.44 59.71 Favored 'General case' 0 CA--C 1.577 2.018 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 176.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.66 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 93.7 m -67.01 138.63 57.36 Favored 'General case' 0 CA--C 1.56 1.345 0 N-CA-C 115.987 1.847 . . . . 0.0 115.987 -168.721 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 18.6 p80 . . . . . 0 CA--C 1.577 2.003 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 -179.039 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.331 41.8 t . . . . . 0 CA--C 1.573 1.828 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.471 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 17.7 p -139.61 -148.94 0.27 Allowed 'General case' 0 CA--C 1.576 1.957 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -160.118 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 38.1 t -121.42 84.87 2.31 Favored 'General case' 0 CA--C 1.572 1.821 0 O-C-N 120.36 -1.462 . . . . 0.0 112.075 148.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 145.54 42.82 0.04 OUTLIER Glycine 0 N--CA 1.503 3.137 0 N-CA-C 118.631 2.212 . . . . 0.0 118.631 176.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.62 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 1.2 t80 -161.96 152.63 14.71 Favored Pre-proline 0 CA--C 1.58 2.106 0 CA-C-N 118.712 1.256 . . . . 0.0 109.121 -174.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -30.5 -55.94 0.2 Allowed 'Trans proline' 0 CA--C 1.569 2.238 0 N-CA-C 121.594 3.651 . . . . 0.0 121.594 174.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.6 mp -79.62 -7.8 58.77 Favored 'General case' 0 CA--C 1.579 2.058 0 N-CA-C 116.628 2.085 . . . . 0.0 116.628 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.62 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 96.7 m -68.0 145.15 54.76 Favored 'General case' 0 CA--C 1.568 1.664 0 N-CA-C 117.564 2.431 . . . . 0.0 117.564 -161.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 27.1 p80 -74.72 161.82 29.29 Favored 'General case' 0 CA--C 1.584 2.265 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 -175.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 34.6 m . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 124.387 2.042 . . . . 0.0 114.208 -168.393 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.303 20.1 t . . . . . 0 CA--C 1.569 1.678 0 N-CA-C 111.122 0.045 . . . . 0.0 111.122 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.475 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 17.1 p -144.13 -152.23 0.41 Allowed 'General case' 0 CA--C 1.575 1.921 0 N-CA-C 115.688 1.736 . . . . 0.0 115.688 -161.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 36.8 t -118.87 83.65 2.06 Favored 'General case' 0 CA--C 1.575 1.941 0 O-C-N 120.317 -1.49 . . . . 0.0 111.862 146.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 147.96 40.13 0.04 OUTLIER Glycine 0 N--CA 1.5 2.939 0 N-CA-C 119.83 2.692 . . . . 0.0 119.83 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.666 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 0.7 OUTLIER -162.04 155.63 17.95 Favored Pre-proline 0 CA--C 1.581 2.138 0 CA-C-N 119.445 1.623 . . . . 0.0 109.271 -175.918 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -31.16 -62.35 0.12 Allowed 'Trans proline' 0 CA--C 1.568 2.217 0 C-N-CA 124.272 3.315 . . . . 0.0 120.685 173.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.5 mp -73.62 -8.78 57.32 Favored 'General case' 0 CA--C 1.577 1.989 0 N-CA-C 117.477 2.399 . . . . 0.0 117.477 178.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.666 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 82.4 m -59.88 137.55 58.04 Favored 'General case' 0 CA--C 1.566 1.561 0 N-CA-C 117.529 2.418 . . . . 0.0 117.529 -161.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 30.2 p80 -68.53 160.7 29.39 Favored 'General case' 0 CA--C 1.578 2.04 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 -176.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 57.2 m . . . . . 0 CA--C 1.561 1.369 0 CA-C-O 124.72 2.2 . . . . 0.0 115.15 -174.424 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.262 35.8 t . . . . . 0 N--CA 1.493 1.694 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.431 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 20.9 p -159.96 -155.35 0.44 Allowed 'General case' 0 CA--C 1.575 1.938 0 C-N-CA 124.041 0.937 . . . . 0.0 113.315 -161.377 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 51.9 t -113.3 113.42 25.24 Favored 'General case' 0 CA--C 1.573 1.862 0 O-C-N 120.751 -1.218 . . . . 0.0 111.425 151.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 109.39 62.86 0.53 Allowed Glycine 0 N--CA 1.5 2.955 0 N-CA-C 118.353 2.101 . . . . 0.0 118.353 169.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.694 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 66.8 t80 -178.21 151.16 0.77 Allowed Pre-proline 0 CA--C 1.582 2.175 0 C-N-CA 125.224 1.409 . . . . 0.0 108.167 -167.124 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -32.78 -54.26 0.37 Allowed 'Trans proline' 0 CA--C 1.568 2.195 0 N-CA-C 121.418 3.584 . . . . 0.0 121.418 169.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.8 mp -84.84 2.17 43.65 Favored 'General case' 0 CA--C 1.58 2.117 0 N-CA-C 116.213 1.931 . . . . 0.0 116.213 177.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.694 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 93.7 m -92.16 129.22 38.16 Favored 'General case' 0 CA--C 1.562 1.434 0 O-C-N 119.882 -1.761 . . . . 0.0 114.248 -169.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 20.7 p80 -73.95 167.79 20.77 Favored 'General case' 0 CA--C 1.581 2.145 0 N-CA-C 117.425 2.38 . . . . 0.0 117.425 -173.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 57.7 m . . . . . 0 N--CA 1.483 1.18 0 CA-C-O 124.228 1.966 . . . . 0.0 114.027 -164.438 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.299 56.1 t . . . . . 0 N--CA 1.494 1.748 0 CA-C-O 119.696 -0.192 . . . . 0.0 110.734 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 17.8 p -147.5 -152.79 0.45 Allowed 'General case' 0 CA--C 1.578 2.035 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -165.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 52.8 t -119.08 73.8 0.95 Allowed 'General case' 0 CA--C 1.576 1.979 0 O-C-N 120.521 -1.362 . . . . 0.0 112.626 154.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 152.6 57.29 0.01 OUTLIER Glycine 0 N--CA 1.502 3.08 0 N-CA-C 118.532 2.173 . . . . 0.0 118.532 173.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.608 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 5.5 t80 -174.65 155.25 2.01 Favored Pre-proline 0 CA--C 1.591 2.539 0 C-N-CA 125.16 1.384 . . . . 0.0 109.694 -172.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -37.33 -55.82 0.92 Allowed 'Trans proline' 0 CA--C 1.57 2.319 0 N-CA-C 121.62 3.662 . . . . 0.0 121.62 173.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.6 mp -78.01 -8.97 58.87 Favored 'General case' 0 CA--C 1.581 2.136 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 175.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.608 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 79.9 m -70.9 135.41 47.97 Favored 'General case' 0 CA--C 1.564 1.508 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 -177.142 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 33.9 p80 -76.99 162.88 27.21 Favored 'General case' 0 CA--C 1.578 2.036 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -177.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 17.0 m . . . . . 0 N--CA 1.484 1.27 0 CA-C-O 124.062 1.887 . . . . 0.0 112.708 -163.283 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.403 ' HB ' ' SG ' ' A' ' 8' ' ' CYS 0.283 54.8 t . . . . . 0 CA--C 1.571 1.762 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.43 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 17.9 p -153.6 -162.66 1.49 Allowed 'General case' 0 CA--C 1.575 1.921 0 N-CA-C 115.216 1.561 . . . . 0.0 115.216 -161.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 44.4 t -101.18 107.57 19.01 Favored 'General case' 0 CA--C 1.573 1.856 0 O-C-N 120.462 -1.399 . . . . 0.0 111.426 146.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 114.1 59.04 0.38 Allowed Glycine 0 N--CA 1.5 2.922 0 N-CA-C 118.101 2.0 . . . . 0.0 118.101 165.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.682 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 8.3 t80 -171.39 154.96 4.04 Favored Pre-proline 0 CA--C 1.586 2.35 0 CA-C-N 118.684 1.242 . . . . 0.0 110.75 -174.092 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -35.86 -53.04 0.94 Allowed 'Trans proline' 0 CA--C 1.568 2.198 0 N-CA-C 122.159 3.869 . . . . 0.0 122.159 173.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.6 mp -81.89 -13.4 57.62 Favored 'General case' 0 CA--C 1.58 2.099 0 N-CA-C 115.81 1.781 . . . . 0.0 115.81 176.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.682 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 98.6 m -68.87 148.84 49.65 Favored 'General case' 0 CA--C 1.562 1.436 0 N-CA-C 116.8 2.148 . . . . 0.0 116.8 -168.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 24.3 p80 -78.29 163.9 25.34 Favored 'General case' 0 CA--C 1.58 2.111 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 176.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 83.1 m . . . . . 0 N--CA 1.485 1.295 0 CA-C-O 125.214 2.435 . . . . 0.0 113.348 -170.186 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.401 ' HB ' ' SG ' ' A' ' 8' ' ' CYS . 23.4 t . . . . . 0 N--CA 1.496 1.856 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.441 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 20.6 p -163.25 -162.8 0.78 Allowed 'General case' 0 CA--C 1.58 2.113 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -161.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 51.1 t -100.67 115.6 30.6 Favored 'General case' 0 CA--C 1.572 1.824 0 O-C-N 120.116 -1.615 . . . . 0.0 112.424 139.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 118.95 47.58 0.39 Allowed Glycine 0 N--CA 1.506 3.326 0 N-CA-C 119.77 2.668 . . . . 0.0 119.77 165.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.688 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 33.1 t80 -170.66 152.77 3.93 Favored Pre-proline 0 CA--C 1.585 2.306 0 CA-C-N 118.869 1.334 . . . . 0.0 110.39 -167.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -33.01 -56.81 0.33 Allowed 'Trans proline' 0 CA--C 1.568 2.199 0 N-CA-C 121.317 3.545 . . . . 0.0 121.317 172.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.3 mp -78.26 -11.25 59.92 Favored 'General case' 0 CA--C 1.58 2.121 0 N-CA-C 116.867 2.173 . . . . 0.0 116.867 178.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.688 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 86.4 m -73.37 155.12 39.7 Favored 'General case' 0 CA--C 1.565 1.543 0 N-CA-C 116.544 2.053 . . . . 0.0 116.544 -170.276 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 27.4 p80 -90.2 166.06 13.58 Favored 'General case' 0 CA--C 1.579 2.09 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 -178.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 53.8 m . . . . . 0 CA--C 1.56 1.361 0 CA-C-O 125.408 2.528 . . . . 0.0 112.85 -165.683 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.325 45.3 t . . . . . 0 CA--C 1.571 1.787 0 CA-C-O 119.872 -0.109 . . . . 0.0 111.004 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 19.2 p -146.3 -155.67 0.64 Allowed 'General case' 0 CA--C 1.578 2.057 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 -160.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 43.2 t -113.58 99.93 8.11 Favored 'General case' 0 CA--C 1.57 1.736 0 O-C-N 120.061 -1.649 . . . . 0.0 110.525 139.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 138.56 33.82 0.18 Allowed Glycine 0 N--CA 1.501 3.019 0 N-CA-C 120.157 2.823 . . . . 0.0 120.157 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.641 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 11.0 t80 -163.23 155.07 15.14 Favored Pre-proline 0 CA--C 1.582 2.186 0 CA-C-N 119.002 1.401 . . . . 0.0 109.299 -178.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -34.74 -61.02 0.26 Allowed 'Trans proline' 0 CA--C 1.568 2.18 0 C-N-CA 124.381 3.387 . . . . 0.0 120.767 172.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.1 mp -73.29 -0.24 13.97 Favored 'General case' 0 CA--C 1.583 2.224 0 N-CA-C 117.282 2.327 . . . . 0.0 117.282 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.641 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 95.7 m -70.31 151.56 45.14 Favored 'General case' 0 CA--C 1.563 1.463 0 N-CA-C 116.514 2.042 . . . . 0.0 116.514 -171.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 16.5 p80 -83.89 161.49 20.84 Favored 'General case' 0 CA--C 1.579 2.096 0 N-CA-C 114.409 1.262 . . . . 0.0 114.409 176.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 79.8 m . . . . . 0 N--CA 1.482 1.146 0 CA-C-O 124.604 2.145 . . . . 0.0 114.016 -169.171 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.447 ' HB ' ' SG ' ' A' ' 8' ' ' CYS 0.297 53.4 t . . . . . 0 CA--C 1.572 1.8 0 N-CA-C 111.593 0.22 . . . . 0.0 111.593 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.414 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 20.3 p -156.77 -148.48 0.22 Allowed 'General case' 0 CA--C 1.581 2.171 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -161.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 15.5 t -112.09 122.99 49.29 Favored 'General case' 0 CA--C 1.573 1.862 0 O-C-N 120.353 -1.467 . . . . 0.0 111.863 155.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 97.47 60.38 0.95 Allowed Glycine 0 N--CA 1.502 3.086 0 N-CA-C 118.34 2.096 . . . . 0.0 118.34 166.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.661 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 53.0 t80 -177.81 151.05 0.82 Allowed Pre-proline 0 CA--C 1.586 2.356 0 C-N-CA 124.882 1.273 . . . . 0.0 109.192 -163.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -36.8 -63.32 0.22 Allowed 'Trans proline' 0 CA--C 1.57 2.277 0 C-N-CA 124.427 3.418 . . . . 0.0 120.34 173.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.4 mp -74.84 -15.96 60.71 Favored 'General case' 0 CA--C 1.579 2.069 0 N-CA-C 116.326 1.973 . . . . 0.0 116.326 176.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.661 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 91.4 m -71.92 141.19 49.48 Favored 'General case' 0 CA--C 1.558 1.285 0 N-CA-C 115.181 1.548 . . . . 0.0 115.181 -174.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 15.1 p80 -73.08 155.8 39.37 Favored 'General case' 0 CA--C 1.577 2.016 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 37.3 m . . . . . 0 CA--C 1.56 1.334 0 CA-C-O 124.883 2.278 . . . . 0.0 112.785 -170.653 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.277 53.6 t . . . . . 0 N--CA 1.494 1.757 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.492 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 19.3 p -152.24 -155.92 0.66 Allowed 'General case' 0 CA--C 1.574 1.867 0 C-N-CA 124.423 1.089 . . . . 0.0 113.033 -165.361 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 14.8 t -80.69 -54.86 5.26 Favored 'General case' 0 CA--C 1.574 1.904 0 N-CA-C 116.263 1.949 . . . . 0.0 116.263 160.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -127.37 85.94 0.33 Allowed Glycine 0 N--CA 1.495 2.581 0 CA-C-N 120.69 1.586 . . . . 0.0 115.936 -165.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.704 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 16.6 t80 -170.82 155.09 4.56 Favored Pre-proline 0 CA--C 1.583 2.241 0 C-N-CA 124.718 1.207 . . . . 0.0 110.004 -173.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -33.89 -48.94 0.54 Allowed 'Trans proline' 0 CA--C 1.566 2.116 0 N-CA-C 121.962 3.793 . . . . 0.0 121.962 173.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 8.3 mp -86.86 -13.1 45.9 Favored 'General case' 0 CA--C 1.578 2.048 0 N-CA-C 116.617 2.081 . . . . 0.0 116.617 178.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.704 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 66.3 m -70.16 166.03 20.81 Favored 'General case' 0 CA--C 1.565 1.536 0 N-CA-C 118.003 2.594 . . . . 0.0 118.003 -162.163 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 27.3 p80 -86.57 163.65 17.33 Favored 'General case' 0 CA--C 1.579 2.064 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 -178.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 72.5 m . . . . . 0 CA--C 1.562 1.44 0 CA-C-O 124.633 2.159 . . . . 0.0 115.503 -168.899 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.292 73.5 t . . . . . 0 N--CA 1.493 1.693 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.47 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 17.0 p -147.45 -151.2 0.37 Allowed 'General case' 0 CA--C 1.575 1.933 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -161.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 11.9 t -87.51 -45.19 10.7 Favored 'General case' 0 CA--C 1.576 1.959 0 N-CA-C 115.877 1.806 . . . . 0.0 115.877 154.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -123.73 75.12 0.38 Allowed Glycine 0 N--CA 1.495 2.63 0 N-CA-C 117.253 1.661 . . . . 0.0 117.253 -167.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.649 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 2.3 t80 -167.62 152.64 6.77 Favored Pre-proline 0 CA--C 1.584 2.262 0 C-N-CA 124.939 1.296 . . . . 0.0 108.956 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -31.0 -54.69 0.24 Allowed 'Trans proline' 0 CA--C 1.569 2.274 0 N-CA-C 122.38 3.954 . . . . 0.0 122.38 173.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.1 mp -85.19 4.8 32.88 Favored 'General case' 0 CA--C 1.585 2.325 0 N-CA-C 116.682 2.104 . . . . 0.0 116.682 178.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.649 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 82.3 m -77.09 144.72 38.31 Favored 'General case' 0 CA--C 1.562 1.441 0 O-C-N 119.602 -1.936 . . . . 0.0 116.012 -167.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 35.5 p80 -66.92 166.05 14.25 Favored 'General case' 0 CA--C 1.584 2.261 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 171.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 76.3 m . . . . . 0 CA--C 1.56 1.362 0 CA-C-O 124.62 2.153 . . . . 0.0 114.375 -173.605 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.281 40.7 t . . . . . 0 N--CA 1.496 1.838 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.479 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 17.6 p -150.94 -147.32 0.23 Allowed 'General case' 0 CA--C 1.575 1.935 0 C-N-CA 124.116 0.966 . . . . 0.0 113.523 -164.313 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 20.8 t -93.79 -56.46 2.88 Favored 'General case' 0 CA--C 1.577 2.007 0 O-C-N 120.733 -1.23 . . . . 0.0 114.051 153.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -108.25 77.34 0.23 Allowed Glycine 0 N--CA 1.498 2.796 0 N-CA-C 118.293 2.077 . . . . 0.0 118.293 -169.177 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.698 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 12.0 t80 -167.09 155.95 9.32 Favored Pre-proline 0 CA--C 1.589 2.461 0 C-N-CA 124.691 1.196 . . . . 0.0 109.915 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -36.06 -46.7 1.05 Allowed 'Trans proline' 0 CA--C 1.567 2.153 0 N-CA-C 122.378 3.953 . . . . 0.0 122.378 172.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.4 mp -86.06 -4.71 59.23 Favored 'General case' 0 CA--C 1.578 2.029 0 N-CA-C 116.083 1.883 . . . . 0.0 116.083 177.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.698 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 95.5 m -75.72 149.37 38.07 Favored 'General case' 0 CA--C 1.564 1.495 0 N-CA-C 117.43 2.381 . . . . 0.0 117.43 -163.03 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 34.3 p80 -81.55 172.36 13.57 Favored 'General case' 0 CA--C 1.581 2.148 0 N-CA-C 114.927 1.454 . . . . 0.0 114.927 -179.057 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 86.5 m . . . . . 0 N--CA 1.484 1.258 0 CA-C-O 125.358 2.504 . . . . 0.0 116.234 -166.372 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.303 24.6 t . . . . . 0 N--CA 1.492 1.659 0 N-CA-C 111.205 0.076 . . . . 0.0 111.205 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.401 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 18.0 p -146.68 -147.49 0.22 Allowed 'General case' 0 CA--C 1.573 1.86 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -160.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 5.8 t -89.18 -49.01 7.0 Favored 'General case' 0 CA--C 1.574 1.878 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 155.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -120.61 72.46 0.35 Allowed Glycine 0 N--CA 1.495 2.619 0 N-CA-C 118.073 1.989 . . . . 0.0 118.073 -166.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.61 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 2.5 t80 -165.14 157.75 13.68 Favored Pre-proline 0 CA--C 1.591 2.54 0 C-N-CA 124.776 1.23 . . . . 0.0 109.132 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -35.75 -49.89 1.03 Allowed 'Trans proline' 0 CA--C 1.566 2.097 0 N-CA-C 122.001 3.808 . . . . 0.0 122.001 172.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 9.1 mp -76.79 -14.56 59.91 Favored 'General case' 0 CA--C 1.579 2.07 0 N-CA-C 116.401 2.001 . . . . 0.0 116.401 175.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.61 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 97.6 m -69.16 148.47 49.88 Favored 'General case' 0 CA--C 1.567 1.631 0 N-CA-C 118.007 2.595 . . . . 0.0 118.007 -162.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 34.0 p80 -83.81 171.01 13.53 Favored 'General case' 0 CA--C 1.581 2.172 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 176.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 77.7 m . . . . . 0 N--CA 1.481 1.082 0 CA-C-O 124.392 2.044 . . . . 0.0 112.71 -172.397 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.317 72.2 t . . . . . 0 CA--C 1.569 1.688 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.419 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 20.3 p -137.19 -147.07 0.23 Allowed 'General case' 0 CA--C 1.574 1.9 0 C-N-CA 124.463 1.105 . . . . 0.0 113.861 -162.205 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 45.7 t -112.61 118.98 36.57 Favored 'General case' 0 CA--C 1.57 1.724 0 O-C-N 120.248 -1.532 . . . . 0.0 110.577 151.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 100.42 64.74 0.8 Allowed Glycine 0 N--CA 1.499 2.895 0 N-CA-C 117.811 1.884 . . . . 0.0 117.811 169.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.688 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 22.6 t80 -179.15 151.1 0.64 Allowed Pre-proline 0 CA--C 1.588 2.419 0 C-N-CA 125.272 1.429 . . . . 0.0 108.66 -172.333 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -34.45 -58.94 0.34 Allowed 'Trans proline' 0 CA--C 1.568 2.221 0 C-N-CA 124.593 3.529 . . . . 0.0 120.931 172.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.8 mp -78.45 -9.48 59.32 Favored 'General case' 0 CA--C 1.583 2.214 0 N-CA-C 116.232 1.938 . . . . 0.0 116.232 177.016 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.688 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 68.3 m -71.42 151.69 43.79 Favored 'General case' 0 CA--C 1.563 1.475 0 N-CA-C 116.774 2.138 . . . . 0.0 116.774 -169.532 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 29.4 p80 -88.85 165.38 14.69 Favored 'General case' 0 CA--C 1.581 2.143 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -179.015 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 51.3 m . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 124.918 2.294 . . . . 0.0 114.622 -162.597 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.303 31.9 t . . . . . 0 N--CA 1.494 1.727 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.425 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 16.8 p -147.64 -158.11 0.88 Allowed 'General case' 0 CA--C 1.576 1.962 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 -162.178 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 29.3 t -104.95 98.06 7.83 Favored 'General case' 0 CA--C 1.574 1.887 0 O-C-N 120.635 -1.29 . . . . 0.0 111.523 147.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 113.81 69.09 0.5 Allowed Glycine 0 N--CA 1.501 2.996 0 N-CA-C 117.692 1.837 . . . . 0.0 117.692 170.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.622 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 1.4 t80 -175.81 154.69 1.51 Allowed Pre-proline 0 CA--C 1.589 2.47 0 C-N-CA 125.612 1.565 . . . . 0.0 108.144 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -32.85 -51.75 0.4 Allowed 'Trans proline' 0 CA--C 1.569 2.237 0 N-CA-C 121.898 3.768 . . . . 0.0 121.898 173.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.9 mp -84.71 -0.64 54.31 Favored 'General case' 0 CA--C 1.582 2.187 0 N-CA-C 116.213 1.931 . . . . 0.0 116.213 177.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.622 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 92.3 m -77.88 146.43 35.63 Favored 'General case' 0 CA--C 1.564 1.503 0 O-C-N 119.478 -2.014 . . . . 0.0 116.383 -165.081 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 21.2 p80 -80.21 161.0 25.42 Favored 'General case' 0 CA--C 1.579 2.075 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 175.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 73.1 m . . . . . 0 N--CA 1.483 1.207 0 CA-C-O 125.441 2.543 . . . . 0.0 116.008 -166.189 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.43 ' HB ' ' SG ' ' A' ' 8' ' ' CYS 0.265 55.4 t . . . . . 0 N--CA 1.495 1.807 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.447 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 19.5 p -159.42 -159.47 0.75 Allowed 'General case' 0 CA--C 1.575 1.936 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -161.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 53.4 t -100.26 132.44 45.62 Favored 'General case' 0 CA--C 1.575 1.932 0 O-C-N 120.307 -1.496 . . . . 0.0 112.224 142.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 93.22 57.32 1.38 Allowed Glycine 0 N--CA 1.499 2.899 0 N-CA-C 118.155 2.022 . . . . 0.0 118.155 165.006 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.668 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 26.2 t80 -173.44 155.88 2.75 Favored Pre-proline 0 CA--C 1.584 2.257 0 CA-C-N 118.597 1.198 . . . . 0.0 110.682 -170.078 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -36.27 -56.98 0.61 Allowed 'Trans proline' 0 CA--C 1.568 2.182 0 N-CA-C 121.076 3.452 . . . . 0.0 121.076 171.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.3 mp -82.47 -6.43 59.3 Favored 'General case' 0 CA--C 1.58 2.115 0 N-CA-C 116.765 2.135 . . . . 0.0 116.765 178.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.668 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 74.3 m -75.39 150.69 38.3 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 116.796 2.147 . . . . 0.0 116.796 -165.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 23.9 p80 -81.92 166.27 20.03 Favored 'General case' 0 CA--C 1.579 2.07 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 59.8 m . . . . . 0 N--CA 1.483 1.187 0 CA-C-O 125.171 2.415 . . . . 0.0 112.381 -169.975 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.297 55.4 t . . . . . 0 CA--C 1.572 1.79 0 N-CA-C 111.355 0.132 . . . . 0.0 111.355 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 17.1 p -148.18 -148.91 0.27 Allowed 'General case' 0 CA--C 1.578 2.031 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 -163.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 41.2 t -124.52 66.42 1.08 Allowed 'General case' 0 CA--C 1.579 2.095 0 O-C-N 120.793 -1.192 . . . . 0.0 112.366 160.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 150.02 61.13 0.01 OUTLIER Glycine 0 N--CA 1.502 3.063 0 N-CA-C 117.393 1.717 . . . . 0.0 117.393 177.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.66 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 3.6 t80 -172.7 153.57 2.74 Favored Pre-proline 0 CA--C 1.588 2.41 0 C-N-CA 125.137 1.375 . . . . 0.0 109.094 -176.276 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -33.53 -54.86 0.44 Allowed 'Trans proline' 0 CA--C 1.564 2.021 0 N-CA-C 121.971 3.797 . . . . 0.0 121.971 173.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.8 mp -81.0 -10.44 59.71 Favored 'General case' 0 CA--C 1.577 2.018 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 176.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.66 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 93.7 m -67.01 138.63 57.36 Favored 'General case' 0 CA--C 1.56 1.345 0 N-CA-C 115.987 1.847 . . . . 0.0 115.987 -168.721 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 18.6 p80 -74.15 156.89 36.87 Favored 'General case' 0 CA--C 1.577 2.003 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 -179.039 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 11.0 m . . . . . 0 CA--C 1.562 1.428 0 CA-C-O 124.991 2.329 . . . . 0.0 112.943 -173.559 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.331 41.8 t . . . . . 0 CA--C 1.573 1.828 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.471 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 17.7 p -139.61 -148.94 0.27 Allowed 'General case' 0 CA--C 1.576 1.957 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -160.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 38.1 t -121.42 84.87 2.31 Favored 'General case' 0 CA--C 1.572 1.821 0 O-C-N 120.36 -1.462 . . . . 0.0 112.075 148.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 145.54 42.82 0.04 OUTLIER Glycine 0 N--CA 1.503 3.137 0 N-CA-C 118.631 2.212 . . . . 0.0 118.631 176.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.62 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 1.2 t80 -161.96 152.63 14.71 Favored Pre-proline 0 CA--C 1.58 2.106 0 CA-C-N 118.712 1.256 . . . . 0.0 109.121 -174.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -30.5 -55.94 0.2 Allowed 'Trans proline' 0 CA--C 1.569 2.238 0 N-CA-C 121.594 3.651 . . . . 0.0 121.594 174.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.6 mp -79.62 -7.8 58.77 Favored 'General case' 0 CA--C 1.579 2.058 0 N-CA-C 116.628 2.085 . . . . 0.0 116.628 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.62 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 96.7 m -68.0 145.15 54.76 Favored 'General case' 0 CA--C 1.568 1.664 0 N-CA-C 117.564 2.431 . . . . 0.0 117.564 -161.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 27.1 p80 . . . . . 0 CA--C 1.584 2.265 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 -175.259 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.303 20.1 t . . . . . 0 CA--C 1.569 1.678 0 N-CA-C 111.122 0.045 . . . . 0.0 111.122 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.475 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 17.1 p -144.13 -152.23 0.41 Allowed 'General case' 0 CA--C 1.575 1.921 0 N-CA-C 115.688 1.736 . . . . 0.0 115.688 -161.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 36.8 t -118.87 83.65 2.06 Favored 'General case' 0 CA--C 1.575 1.941 0 O-C-N 120.317 -1.49 . . . . 0.0 111.862 146.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 147.96 40.13 0.04 OUTLIER Glycine 0 N--CA 1.5 2.939 0 N-CA-C 119.83 2.692 . . . . 0.0 119.83 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.666 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 0.7 OUTLIER -162.04 155.63 17.95 Favored Pre-proline 0 CA--C 1.581 2.138 0 CA-C-N 119.445 1.623 . . . . 0.0 109.271 -175.918 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -31.16 -62.35 0.12 Allowed 'Trans proline' 0 CA--C 1.568 2.217 0 C-N-CA 124.272 3.315 . . . . 0.0 120.685 173.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.5 mp -73.62 -8.78 57.32 Favored 'General case' 0 CA--C 1.577 1.989 0 N-CA-C 117.477 2.399 . . . . 0.0 117.477 178.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.666 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 82.4 m -59.88 137.55 58.04 Favored 'General case' 0 CA--C 1.566 1.561 0 N-CA-C 117.529 2.418 . . . . 0.0 117.529 -161.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 30.2 p80 . . . . . 0 CA--C 1.578 2.04 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 -176.214 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.262 35.8 t . . . . . 0 N--CA 1.493 1.694 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.431 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 20.9 p -159.96 -155.35 0.44 Allowed 'General case' 0 CA--C 1.575 1.938 0 C-N-CA 124.041 0.937 . . . . 0.0 113.315 -161.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 51.9 t -113.3 113.42 25.24 Favored 'General case' 0 CA--C 1.573 1.862 0 O-C-N 120.751 -1.218 . . . . 0.0 111.425 151.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 109.39 62.86 0.53 Allowed Glycine 0 N--CA 1.5 2.955 0 N-CA-C 118.353 2.101 . . . . 0.0 118.353 169.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.694 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 66.8 t80 -178.21 151.16 0.77 Allowed Pre-proline 0 CA--C 1.582 2.175 0 C-N-CA 125.224 1.409 . . . . 0.0 108.167 -167.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -32.78 -54.26 0.37 Allowed 'Trans proline' 0 CA--C 1.568 2.195 0 N-CA-C 121.418 3.584 . . . . 0.0 121.418 169.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.8 mp -84.84 2.17 43.65 Favored 'General case' 0 CA--C 1.58 2.117 0 N-CA-C 116.213 1.931 . . . . 0.0 116.213 177.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.694 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 93.7 m -92.16 129.22 38.16 Favored 'General case' 0 CA--C 1.562 1.434 0 O-C-N 119.882 -1.761 . . . . 0.0 114.248 -169.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 20.7 p80 . . . . . 0 CA--C 1.581 2.145 0 N-CA-C 117.425 2.38 . . . . 0.0 117.425 -173.081 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.299 56.1 t . . . . . 0 N--CA 1.494 1.748 0 CA-C-O 119.696 -0.192 . . . . 0.0 110.734 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 17.8 p -147.5 -152.79 0.45 Allowed 'General case' 0 CA--C 1.578 2.035 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -165.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 52.8 t -119.08 73.8 0.95 Allowed 'General case' 0 CA--C 1.576 1.979 0 O-C-N 120.521 -1.362 . . . . 0.0 112.626 154.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 152.6 57.29 0.01 OUTLIER Glycine 0 N--CA 1.502 3.08 0 N-CA-C 118.532 2.173 . . . . 0.0 118.532 173.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.608 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 5.5 t80 -174.65 155.25 2.01 Favored Pre-proline 0 CA--C 1.591 2.539 0 C-N-CA 125.16 1.384 . . . . 0.0 109.694 -172.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -37.33 -55.82 0.92 Allowed 'Trans proline' 0 CA--C 1.57 2.319 0 N-CA-C 121.62 3.662 . . . . 0.0 121.62 173.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.6 mp -78.01 -8.97 58.87 Favored 'General case' 0 CA--C 1.581 2.136 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 175.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.608 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 79.9 m -70.9 135.41 47.97 Favored 'General case' 0 CA--C 1.564 1.508 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 -177.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 33.9 p80 . . . . . 0 CA--C 1.578 2.036 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -177.479 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . 0.403 ' HB ' ' SG ' ' A' ' 8' ' ' CYS 0.283 54.8 t . . . . . 0 CA--C 1.571 1.762 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.43 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 17.9 p -153.6 -162.66 1.49 Allowed 'General case' 0 CA--C 1.575 1.921 0 N-CA-C 115.216 1.561 . . . . 0.0 115.216 -161.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 44.4 t -101.18 107.57 19.01 Favored 'General case' 0 CA--C 1.573 1.856 0 O-C-N 120.462 -1.399 . . . . 0.0 111.426 146.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 114.1 59.04 0.38 Allowed Glycine 0 N--CA 1.5 2.922 0 N-CA-C 118.101 2.0 . . . . 0.0 118.101 165.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.682 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 8.3 t80 -171.39 154.96 4.04 Favored Pre-proline 0 CA--C 1.586 2.35 0 CA-C-N 118.684 1.242 . . . . 0.0 110.75 -174.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -35.86 -53.04 0.94 Allowed 'Trans proline' 0 CA--C 1.568 2.198 0 N-CA-C 122.159 3.869 . . . . 0.0 122.159 173.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.6 mp -81.89 -13.4 57.62 Favored 'General case' 0 CA--C 1.58 2.099 0 N-CA-C 115.81 1.781 . . . . 0.0 115.81 176.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.682 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 98.6 m -68.87 148.84 49.65 Favored 'General case' 0 CA--C 1.562 1.436 0 N-CA-C 116.8 2.148 . . . . 0.0 116.8 -168.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 24.3 p80 . . . . . 0 CA--C 1.58 2.111 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 176.303 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . 0.401 ' HB ' ' SG ' ' A' ' 8' ' ' CYS . 23.4 t . . . . . 0 N--CA 1.496 1.856 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.441 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 20.6 p -163.25 -162.8 0.78 Allowed 'General case' 0 CA--C 1.58 2.113 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -161.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 51.1 t -100.67 115.6 30.6 Favored 'General case' 0 CA--C 1.572 1.824 0 O-C-N 120.116 -1.615 . . . . 0.0 112.424 139.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 118.95 47.58 0.39 Allowed Glycine 0 N--CA 1.506 3.326 0 N-CA-C 119.77 2.668 . . . . 0.0 119.77 165.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.688 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 33.1 t80 -170.66 152.77 3.93 Favored Pre-proline 0 CA--C 1.585 2.306 0 CA-C-N 118.869 1.334 . . . . 0.0 110.39 -167.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -33.01 -56.81 0.33 Allowed 'Trans proline' 0 CA--C 1.568 2.199 0 N-CA-C 121.317 3.545 . . . . 0.0 121.317 172.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.3 mp -78.26 -11.25 59.92 Favored 'General case' 0 CA--C 1.58 2.121 0 N-CA-C 116.867 2.173 . . . . 0.0 116.867 178.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.688 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 86.4 m -73.37 155.12 39.7 Favored 'General case' 0 CA--C 1.565 1.543 0 N-CA-C 116.544 2.053 . . . . 0.0 116.544 -170.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 27.4 p80 . . . . . 0 CA--C 1.579 2.09 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 -178.464 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.325 45.3 t . . . . . 0 CA--C 1.571 1.787 0 CA-C-O 119.872 -0.109 . . . . 0.0 111.004 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 19.2 p -146.3 -155.67 0.64 Allowed 'General case' 0 CA--C 1.578 2.057 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 -160.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 43.2 t -113.58 99.93 8.11 Favored 'General case' 0 CA--C 1.57 1.736 0 O-C-N 120.061 -1.649 . . . . 0.0 110.525 139.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 138.56 33.82 0.18 Allowed Glycine 0 N--CA 1.501 3.019 0 N-CA-C 120.157 2.823 . . . . 0.0 120.157 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.641 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 11.0 t80 -163.23 155.07 15.14 Favored Pre-proline 0 CA--C 1.582 2.186 0 CA-C-N 119.002 1.401 . . . . 0.0 109.299 -178.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -34.74 -61.02 0.26 Allowed 'Trans proline' 0 CA--C 1.568 2.18 0 C-N-CA 124.381 3.387 . . . . 0.0 120.767 172.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.1 mp -73.29 -0.24 13.97 Favored 'General case' 0 CA--C 1.583 2.224 0 N-CA-C 117.282 2.327 . . . . 0.0 117.282 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.641 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 95.7 m -70.31 151.56 45.14 Favored 'General case' 0 CA--C 1.563 1.463 0 N-CA-C 116.514 2.042 . . . . 0.0 116.514 -171.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 16.5 p80 . . . . . 0 CA--C 1.579 2.096 0 N-CA-C 114.409 1.262 . . . . 0.0 114.409 176.687 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . 0.447 ' HB ' ' SG ' ' A' ' 8' ' ' CYS 0.297 53.4 t . . . . . 0 CA--C 1.572 1.8 0 N-CA-C 111.593 0.22 . . . . 0.0 111.593 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.414 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 20.3 p -156.77 -148.48 0.22 Allowed 'General case' 0 CA--C 1.581 2.171 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -161.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 15.5 t -112.09 122.99 49.29 Favored 'General case' 0 CA--C 1.573 1.862 0 O-C-N 120.353 -1.467 . . . . 0.0 111.863 155.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 97.47 60.38 0.95 Allowed Glycine 0 N--CA 1.502 3.086 0 N-CA-C 118.34 2.096 . . . . 0.0 118.34 166.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.661 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 53.0 t80 -177.81 151.05 0.82 Allowed Pre-proline 0 CA--C 1.586 2.356 0 C-N-CA 124.882 1.273 . . . . 0.0 109.192 -163.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -36.8 -63.32 0.22 Allowed 'Trans proline' 0 CA--C 1.57 2.277 0 C-N-CA 124.427 3.418 . . . . 0.0 120.34 173.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.4 mp -74.84 -15.96 60.71 Favored 'General case' 0 CA--C 1.579 2.069 0 N-CA-C 116.326 1.973 . . . . 0.0 116.326 176.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.661 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 91.4 m -71.92 141.19 49.48 Favored 'General case' 0 CA--C 1.558 1.285 0 N-CA-C 115.181 1.548 . . . . 0.0 115.181 -174.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 15.1 p80 . . . . . 0 CA--C 1.577 2.016 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 -179.532 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.277 53.6 t . . . . . 0 N--CA 1.494 1.757 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.492 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 19.3 p -152.24 -155.92 0.66 Allowed 'General case' 0 CA--C 1.574 1.867 0 C-N-CA 124.423 1.089 . . . . 0.0 113.033 -165.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 14.8 t -80.69 -54.86 5.26 Favored 'General case' 0 CA--C 1.574 1.904 0 N-CA-C 116.263 1.949 . . . . 0.0 116.263 160.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -127.37 85.94 0.33 Allowed Glycine 0 N--CA 1.495 2.581 0 CA-C-N 120.69 1.586 . . . . 0.0 115.936 -165.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.704 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 16.6 t80 -170.82 155.09 4.56 Favored Pre-proline 0 CA--C 1.583 2.241 0 C-N-CA 124.718 1.207 . . . . 0.0 110.004 -173.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -33.89 -48.94 0.54 Allowed 'Trans proline' 0 CA--C 1.566 2.116 0 N-CA-C 121.962 3.793 . . . . 0.0 121.962 173.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 8.3 mp -86.86 -13.1 45.9 Favored 'General case' 0 CA--C 1.578 2.048 0 N-CA-C 116.617 2.081 . . . . 0.0 116.617 178.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.704 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 66.3 m -70.16 166.03 20.81 Favored 'General case' 0 CA--C 1.565 1.536 0 N-CA-C 118.003 2.594 . . . . 0.0 118.003 -162.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 27.3 p80 . . . . . 0 CA--C 1.579 2.064 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 -178.085 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.292 73.5 t . . . . . 0 N--CA 1.493 1.693 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.47 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 17.0 p -147.45 -151.2 0.37 Allowed 'General case' 0 CA--C 1.575 1.933 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -161.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 11.9 t -87.51 -45.19 10.7 Favored 'General case' 0 CA--C 1.576 1.959 0 N-CA-C 115.877 1.806 . . . . 0.0 115.877 154.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -123.73 75.12 0.38 Allowed Glycine 0 N--CA 1.495 2.63 0 N-CA-C 117.253 1.661 . . . . 0.0 117.253 -167.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.649 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 2.3 t80 -167.62 152.64 6.77 Favored Pre-proline 0 CA--C 1.584 2.262 0 C-N-CA 124.939 1.296 . . . . 0.0 108.956 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -31.0 -54.69 0.24 Allowed 'Trans proline' 0 CA--C 1.569 2.274 0 N-CA-C 122.38 3.954 . . . . 0.0 122.38 173.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.1 mp -85.19 4.8 32.88 Favored 'General case' 0 CA--C 1.585 2.325 0 N-CA-C 116.682 2.104 . . . . 0.0 116.682 178.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.649 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 82.3 m -77.09 144.72 38.31 Favored 'General case' 0 CA--C 1.562 1.441 0 O-C-N 119.602 -1.936 . . . . 0.0 116.012 -167.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 35.5 p80 . . . . . 0 CA--C 1.584 2.261 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 171.924 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.281 40.7 t . . . . . 0 N--CA 1.496 1.838 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.479 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 17.6 p -150.94 -147.32 0.23 Allowed 'General case' 0 CA--C 1.575 1.935 0 C-N-CA 124.116 0.966 . . . . 0.0 113.523 -164.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 20.8 t -93.79 -56.46 2.88 Favored 'General case' 0 CA--C 1.577 2.007 0 O-C-N 120.733 -1.23 . . . . 0.0 114.051 153.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -108.25 77.34 0.23 Allowed Glycine 0 N--CA 1.498 2.796 0 N-CA-C 118.293 2.077 . . . . 0.0 118.293 -169.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.698 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 12.0 t80 -167.09 155.95 9.32 Favored Pre-proline 0 CA--C 1.589 2.461 0 C-N-CA 124.691 1.196 . . . . 0.0 109.915 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -36.06 -46.7 1.05 Allowed 'Trans proline' 0 CA--C 1.567 2.153 0 N-CA-C 122.378 3.953 . . . . 0.0 122.378 172.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.4 mp -86.06 -4.71 59.23 Favored 'General case' 0 CA--C 1.578 2.029 0 N-CA-C 116.083 1.883 . . . . 0.0 116.083 177.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.698 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 95.5 m -75.72 149.37 38.07 Favored 'General case' 0 CA--C 1.564 1.495 0 N-CA-C 117.43 2.381 . . . . 0.0 117.43 -163.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 34.3 p80 . . . . . 0 CA--C 1.581 2.148 0 N-CA-C 114.927 1.454 . . . . 0.0 114.927 -179.057 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.303 24.6 t . . . . . 0 N--CA 1.492 1.659 0 N-CA-C 111.205 0.076 . . . . 0.0 111.205 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.401 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 18.0 p -146.68 -147.49 0.22 Allowed 'General case' 0 CA--C 1.573 1.86 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -160.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 5.8 t -89.18 -49.01 7.0 Favored 'General case' 0 CA--C 1.574 1.878 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 155.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -120.61 72.46 0.35 Allowed Glycine 0 N--CA 1.495 2.619 0 N-CA-C 118.073 1.989 . . . . 0.0 118.073 -166.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.61 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 2.5 t80 -165.14 157.75 13.68 Favored Pre-proline 0 CA--C 1.591 2.54 0 C-N-CA 124.776 1.23 . . . . 0.0 109.132 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -35.75 -49.89 1.03 Allowed 'Trans proline' 0 CA--C 1.566 2.097 0 N-CA-C 122.001 3.808 . . . . 0.0 122.001 172.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 9.1 mp -76.79 -14.56 59.91 Favored 'General case' 0 CA--C 1.579 2.07 0 N-CA-C 116.401 2.001 . . . . 0.0 116.401 175.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.61 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 97.6 m -69.16 148.47 49.88 Favored 'General case' 0 CA--C 1.567 1.631 0 N-CA-C 118.007 2.595 . . . . 0.0 118.007 -162.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 34.0 p80 . . . . . 0 CA--C 1.581 2.172 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 176.633 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.317 72.2 t . . . . . 0 CA--C 1.569 1.688 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.419 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 20.3 p -137.19 -147.07 0.23 Allowed 'General case' 0 CA--C 1.574 1.9 0 C-N-CA 124.463 1.105 . . . . 0.0 113.861 -162.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 45.7 t -112.61 118.98 36.57 Favored 'General case' 0 CA--C 1.57 1.724 0 O-C-N 120.248 -1.532 . . . . 0.0 110.577 151.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 100.42 64.74 0.8 Allowed Glycine 0 N--CA 1.499 2.895 0 N-CA-C 117.811 1.884 . . . . 0.0 117.811 169.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.688 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 22.6 t80 -179.15 151.1 0.64 Allowed Pre-proline 0 CA--C 1.588 2.419 0 C-N-CA 125.272 1.429 . . . . 0.0 108.66 -172.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -34.45 -58.94 0.34 Allowed 'Trans proline' 0 CA--C 1.568 2.221 0 C-N-CA 124.593 3.529 . . . . 0.0 120.931 172.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.8 mp -78.45 -9.48 59.32 Favored 'General case' 0 CA--C 1.583 2.214 0 N-CA-C 116.232 1.938 . . . . 0.0 116.232 177.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.688 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 68.3 m -71.42 151.69 43.79 Favored 'General case' 0 CA--C 1.563 1.475 0 N-CA-C 116.774 2.138 . . . . 0.0 116.774 -169.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 29.4 p80 . . . . . 0 CA--C 1.581 2.143 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -179.015 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.303 31.9 t . . . . . 0 N--CA 1.494 1.727 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.425 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 16.8 p -147.64 -158.11 0.88 Allowed 'General case' 0 CA--C 1.576 1.962 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 -162.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 29.3 t -104.95 98.06 7.83 Favored 'General case' 0 CA--C 1.574 1.887 0 O-C-N 120.635 -1.29 . . . . 0.0 111.523 147.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 113.81 69.09 0.5 Allowed Glycine 0 N--CA 1.501 2.996 0 N-CA-C 117.692 1.837 . . . . 0.0 117.692 170.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.622 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 1.4 t80 -175.81 154.69 1.51 Allowed Pre-proline 0 CA--C 1.589 2.47 0 C-N-CA 125.612 1.565 . . . . 0.0 108.144 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -32.85 -51.75 0.4 Allowed 'Trans proline' 0 CA--C 1.569 2.237 0 N-CA-C 121.898 3.768 . . . . 0.0 121.898 173.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.9 mp -84.71 -0.64 54.31 Favored 'General case' 0 CA--C 1.582 2.187 0 N-CA-C 116.213 1.931 . . . . 0.0 116.213 177.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.622 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 92.3 m -77.88 146.43 35.63 Favored 'General case' 0 CA--C 1.564 1.503 0 O-C-N 119.478 -2.014 . . . . 0.0 116.383 -165.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 21.2 p80 . . . . . 0 CA--C 1.579 2.075 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 175.31 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . 0.43 ' HB ' ' SG ' ' A' ' 8' ' ' CYS 0.265 55.4 t . . . . . 0 N--CA 1.495 1.807 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.447 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 19.5 p -159.42 -159.47 0.75 Allowed 'General case' 0 CA--C 1.575 1.936 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -161.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 53.4 t -100.26 132.44 45.62 Favored 'General case' 0 CA--C 1.575 1.932 0 O-C-N 120.307 -1.496 . . . . 0.0 112.224 142.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 93.22 57.32 1.38 Allowed Glycine 0 N--CA 1.499 2.899 0 N-CA-C 118.155 2.022 . . . . 0.0 118.155 165.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.668 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 26.2 t80 -173.44 155.88 2.75 Favored Pre-proline 0 CA--C 1.584 2.257 0 CA-C-N 118.597 1.198 . . . . 0.0 110.682 -170.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -36.27 -56.98 0.61 Allowed 'Trans proline' 0 CA--C 1.568 2.182 0 N-CA-C 121.076 3.452 . . . . 0.0 121.076 171.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.3 mp -82.47 -6.43 59.3 Favored 'General case' 0 CA--C 1.58 2.115 0 N-CA-C 116.765 2.135 . . . . 0.0 116.765 178.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.668 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 74.3 m -75.39 150.69 38.3 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 116.796 2.147 . . . . 0.0 116.796 -165.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 23.9 p80 . . . . . 0 CA--C 1.579 2.07 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 179.886 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.297 55.4 t . . . . . 0 CA--C 1.572 1.79 0 N-CA-C 111.355 0.132 . . . . 0.0 111.355 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 17.1 p -148.18 -148.91 0.27 Allowed 'General case' 0 CA--C 1.578 2.031 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 -163.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 41.2 t -124.52 66.42 1.08 Allowed 'General case' 0 CA--C 1.579 2.095 0 O-C-N 120.793 -1.192 . . . . 0.0 112.366 160.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 150.02 61.13 0.01 OUTLIER Glycine 0 N--CA 1.502 3.063 0 N-CA-C 117.393 1.717 . . . . 0.0 117.393 177.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.66 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 3.6 t80 -172.7 153.57 2.74 Favored Pre-proline 0 CA--C 1.588 2.41 0 C-N-CA 125.137 1.375 . . . . 0.0 109.094 -176.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -33.53 -54.86 0.44 Allowed 'Trans proline' 0 CA--C 1.564 2.021 0 N-CA-C 121.971 3.797 . . . . 0.0 121.971 173.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.8 mp -81.0 -10.44 59.71 Favored 'General case' 0 CA--C 1.577 2.018 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 176.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.66 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 93.7 m -67.01 138.63 57.36 Favored 'General case' 0 CA--C 1.56 1.345 0 N-CA-C 115.987 1.847 . . . . 0.0 115.987 -168.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 18.6 p80 . . . . . 0 CA--C 1.577 2.003 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 -179.039 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.331 41.8 t . . . . . 0 CA--C 1.573 1.828 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.471 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 17.7 p -139.61 -148.94 0.27 Allowed 'General case' 0 CA--C 1.576 1.957 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -160.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 38.1 t -121.42 84.87 2.31 Favored 'General case' 0 CA--C 1.572 1.821 0 O-C-N 120.36 -1.462 . . . . 0.0 112.075 148.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 145.54 42.82 0.04 OUTLIER Glycine 0 N--CA 1.503 3.137 0 N-CA-C 118.631 2.212 . . . . 0.0 118.631 176.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.62 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 1.2 t80 -161.96 152.63 14.71 Favored Pre-proline 0 CA--C 1.58 2.106 0 CA-C-N 118.712 1.256 . . . . 0.0 109.121 -174.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -30.5 -55.94 0.2 Allowed 'Trans proline' 0 CA--C 1.569 2.238 0 N-CA-C 121.594 3.651 . . . . 0.0 121.594 174.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.6 mp -79.62 -7.8 58.77 Favored 'General case' 0 CA--C 1.579 2.058 0 N-CA-C 116.628 2.085 . . . . 0.0 116.628 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.62 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 96.7 m -68.0 145.15 54.76 Favored 'General case' 0 CA--C 1.568 1.664 0 N-CA-C 117.564 2.431 . . . . 0.0 117.564 -161.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 27.1 p80 -74.72 161.82 29.29 Favored 'General case' 0 CA--C 1.584 2.265 0 N-CA-C 116.108 1.892 . . . . 0.0 116.108 -175.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 34.6 m . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 124.387 2.042 . . . . 0.0 114.208 -168.393 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.303 20.1 t . . . . . 0 CA--C 1.569 1.678 0 N-CA-C 111.122 0.045 . . . . 0.0 111.122 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.475 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 17.1 p -144.13 -152.23 0.41 Allowed 'General case' 0 CA--C 1.575 1.921 0 N-CA-C 115.688 1.736 . . . . 0.0 115.688 -161.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 36.8 t -118.87 83.65 2.06 Favored 'General case' 0 CA--C 1.575 1.941 0 O-C-N 120.317 -1.49 . . . . 0.0 111.862 146.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 147.96 40.13 0.04 OUTLIER Glycine 0 N--CA 1.5 2.939 0 N-CA-C 119.83 2.692 . . . . 0.0 119.83 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.666 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 0.7 OUTLIER -162.04 155.63 17.95 Favored Pre-proline 0 CA--C 1.581 2.138 0 CA-C-N 119.445 1.623 . . . . 0.0 109.271 -175.918 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -31.16 -62.35 0.12 Allowed 'Trans proline' 0 CA--C 1.568 2.217 0 C-N-CA 124.272 3.315 . . . . 0.0 120.685 173.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.5 mp -73.62 -8.78 57.32 Favored 'General case' 0 CA--C 1.577 1.989 0 N-CA-C 117.477 2.399 . . . . 0.0 117.477 178.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.666 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 82.4 m -59.88 137.55 58.04 Favored 'General case' 0 CA--C 1.566 1.561 0 N-CA-C 117.529 2.418 . . . . 0.0 117.529 -161.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 30.2 p80 -68.53 160.7 29.39 Favored 'General case' 0 CA--C 1.578 2.04 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 -176.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 57.2 m . . . . . 0 CA--C 1.561 1.369 0 CA-C-O 124.72 2.2 . . . . 0.0 115.15 -174.424 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.262 35.8 t . . . . . 0 N--CA 1.493 1.694 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.431 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 20.9 p -159.96 -155.35 0.44 Allowed 'General case' 0 CA--C 1.575 1.938 0 C-N-CA 124.041 0.937 . . . . 0.0 113.315 -161.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 51.9 t -113.3 113.42 25.24 Favored 'General case' 0 CA--C 1.573 1.862 0 O-C-N 120.751 -1.218 . . . . 0.0 111.425 151.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 109.39 62.86 0.53 Allowed Glycine 0 N--CA 1.5 2.955 0 N-CA-C 118.353 2.101 . . . . 0.0 118.353 169.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.694 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 66.8 t80 -178.21 151.16 0.77 Allowed Pre-proline 0 CA--C 1.582 2.175 0 C-N-CA 125.224 1.409 . . . . 0.0 108.167 -167.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -32.78 -54.26 0.37 Allowed 'Trans proline' 0 CA--C 1.568 2.195 0 N-CA-C 121.418 3.584 . . . . 0.0 121.418 169.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.8 mp -84.84 2.17 43.65 Favored 'General case' 0 CA--C 1.58 2.117 0 N-CA-C 116.213 1.931 . . . . 0.0 116.213 177.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.694 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 93.7 m -92.16 129.22 38.16 Favored 'General case' 0 CA--C 1.562 1.434 0 O-C-N 119.882 -1.761 . . . . 0.0 114.248 -169.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 20.7 p80 -73.95 167.79 20.77 Favored 'General case' 0 CA--C 1.581 2.145 0 N-CA-C 117.425 2.38 . . . . 0.0 117.425 -173.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 57.7 m . . . . . 0 N--CA 1.483 1.18 0 CA-C-O 124.228 1.966 . . . . 0.0 114.027 -164.438 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.299 56.1 t . . . . . 0 N--CA 1.494 1.748 0 CA-C-O 119.696 -0.192 . . . . 0.0 110.734 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 17.8 p -147.5 -152.79 0.45 Allowed 'General case' 0 CA--C 1.578 2.035 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -165.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 52.8 t -119.08 73.8 0.95 Allowed 'General case' 0 CA--C 1.576 1.979 0 O-C-N 120.521 -1.362 . . . . 0.0 112.626 154.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 152.6 57.29 0.01 OUTLIER Glycine 0 N--CA 1.502 3.08 0 N-CA-C 118.532 2.173 . . . . 0.0 118.532 173.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.608 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 5.5 t80 -174.65 155.25 2.01 Favored Pre-proline 0 CA--C 1.591 2.539 0 C-N-CA 125.16 1.384 . . . . 0.0 109.694 -172.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -37.33 -55.82 0.92 Allowed 'Trans proline' 0 CA--C 1.57 2.319 0 N-CA-C 121.62 3.662 . . . . 0.0 121.62 173.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.6 mp -78.01 -8.97 58.87 Favored 'General case' 0 CA--C 1.581 2.136 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 175.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.608 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 79.9 m -70.9 135.41 47.97 Favored 'General case' 0 CA--C 1.564 1.508 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 -177.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 33.9 p80 -76.99 162.88 27.21 Favored 'General case' 0 CA--C 1.578 2.036 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -177.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 17.0 m . . . . . 0 N--CA 1.484 1.27 0 CA-C-O 124.062 1.887 . . . . 0.0 112.708 -163.283 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.403 ' HB ' ' SG ' ' A' ' 8' ' ' CYS 0.283 54.8 t . . . . . 0 CA--C 1.571 1.762 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.43 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 17.9 p -153.6 -162.66 1.49 Allowed 'General case' 0 CA--C 1.575 1.921 0 N-CA-C 115.216 1.561 . . . . 0.0 115.216 -161.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 44.4 t -101.18 107.57 19.01 Favored 'General case' 0 CA--C 1.573 1.856 0 O-C-N 120.462 -1.399 . . . . 0.0 111.426 146.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 114.1 59.04 0.38 Allowed Glycine 0 N--CA 1.5 2.922 0 N-CA-C 118.101 2.0 . . . . 0.0 118.101 165.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.682 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 8.3 t80 -171.39 154.96 4.04 Favored Pre-proline 0 CA--C 1.586 2.35 0 CA-C-N 118.684 1.242 . . . . 0.0 110.75 -174.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -35.86 -53.04 0.94 Allowed 'Trans proline' 0 CA--C 1.568 2.198 0 N-CA-C 122.159 3.869 . . . . 0.0 122.159 173.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.6 mp -81.89 -13.4 57.62 Favored 'General case' 0 CA--C 1.58 2.099 0 N-CA-C 115.81 1.781 . . . . 0.0 115.81 176.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.682 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 98.6 m -68.87 148.84 49.65 Favored 'General case' 0 CA--C 1.562 1.436 0 N-CA-C 116.8 2.148 . . . . 0.0 116.8 -168.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 24.3 p80 -78.29 163.9 25.34 Favored 'General case' 0 CA--C 1.58 2.111 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 176.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 83.1 m . . . . . 0 N--CA 1.485 1.295 0 CA-C-O 125.214 2.435 . . . . 0.0 113.348 -170.186 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.401 ' HB ' ' SG ' ' A' ' 8' ' ' CYS . 23.4 t . . . . . 0 N--CA 1.496 1.856 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.441 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 20.6 p -163.25 -162.8 0.78 Allowed 'General case' 0 CA--C 1.58 2.113 0 N-CA-C 114.833 1.42 . . . . 0.0 114.833 -161.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 51.1 t -100.67 115.6 30.6 Favored 'General case' 0 CA--C 1.572 1.824 0 O-C-N 120.116 -1.615 . . . . 0.0 112.424 139.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 118.95 47.58 0.39 Allowed Glycine 0 N--CA 1.506 3.326 0 N-CA-C 119.77 2.668 . . . . 0.0 119.77 165.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.688 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 33.1 t80 -170.66 152.77 3.93 Favored Pre-proline 0 CA--C 1.585 2.306 0 CA-C-N 118.869 1.334 . . . . 0.0 110.39 -167.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -33.01 -56.81 0.33 Allowed 'Trans proline' 0 CA--C 1.568 2.199 0 N-CA-C 121.317 3.545 . . . . 0.0 121.317 172.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.3 mp -78.26 -11.25 59.92 Favored 'General case' 0 CA--C 1.58 2.121 0 N-CA-C 116.867 2.173 . . . . 0.0 116.867 178.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.688 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 86.4 m -73.37 155.12 39.7 Favored 'General case' 0 CA--C 1.565 1.543 0 N-CA-C 116.544 2.053 . . . . 0.0 116.544 -170.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 27.4 p80 -90.2 166.06 13.58 Favored 'General case' 0 CA--C 1.579 2.09 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 -178.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 53.8 m . . . . . 0 CA--C 1.56 1.361 0 CA-C-O 125.408 2.528 . . . . 0.0 112.85 -165.683 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.325 45.3 t . . . . . 0 CA--C 1.571 1.787 0 CA-C-O 119.872 -0.109 . . . . 0.0 111.004 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 19.2 p -146.3 -155.67 0.64 Allowed 'General case' 0 CA--C 1.578 2.057 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 -160.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 43.2 t -113.58 99.93 8.11 Favored 'General case' 0 CA--C 1.57 1.736 0 O-C-N 120.061 -1.649 . . . . 0.0 110.525 139.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 138.56 33.82 0.18 Allowed Glycine 0 N--CA 1.501 3.019 0 N-CA-C 120.157 2.823 . . . . 0.0 120.157 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.641 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 11.0 t80 -163.23 155.07 15.14 Favored Pre-proline 0 CA--C 1.582 2.186 0 CA-C-N 119.002 1.401 . . . . 0.0 109.299 -178.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -34.74 -61.02 0.26 Allowed 'Trans proline' 0 CA--C 1.568 2.18 0 C-N-CA 124.381 3.387 . . . . 0.0 120.767 172.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.1 mp -73.29 -0.24 13.97 Favored 'General case' 0 CA--C 1.583 2.224 0 N-CA-C 117.282 2.327 . . . . 0.0 117.282 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.641 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 95.7 m -70.31 151.56 45.14 Favored 'General case' 0 CA--C 1.563 1.463 0 N-CA-C 116.514 2.042 . . . . 0.0 116.514 -171.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 16.5 p80 -83.89 161.49 20.84 Favored 'General case' 0 CA--C 1.579 2.096 0 N-CA-C 114.409 1.262 . . . . 0.0 114.409 176.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 79.8 m . . . . . 0 N--CA 1.482 1.146 0 CA-C-O 124.604 2.145 . . . . 0.0 114.016 -169.171 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.447 ' HB ' ' SG ' ' A' ' 8' ' ' CYS 0.297 53.4 t . . . . . 0 CA--C 1.572 1.8 0 N-CA-C 111.593 0.22 . . . . 0.0 111.593 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.414 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 20.3 p -156.77 -148.48 0.22 Allowed 'General case' 0 CA--C 1.581 2.171 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -161.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 15.5 t -112.09 122.99 49.29 Favored 'General case' 0 CA--C 1.573 1.862 0 O-C-N 120.353 -1.467 . . . . 0.0 111.863 155.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 97.47 60.38 0.95 Allowed Glycine 0 N--CA 1.502 3.086 0 N-CA-C 118.34 2.096 . . . . 0.0 118.34 166.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.661 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 53.0 t80 -177.81 151.05 0.82 Allowed Pre-proline 0 CA--C 1.586 2.356 0 C-N-CA 124.882 1.273 . . . . 0.0 109.192 -163.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -36.8 -63.32 0.22 Allowed 'Trans proline' 0 CA--C 1.57 2.277 0 C-N-CA 124.427 3.418 . . . . 0.0 120.34 173.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.4 mp -74.84 -15.96 60.71 Favored 'General case' 0 CA--C 1.579 2.069 0 N-CA-C 116.326 1.973 . . . . 0.0 116.326 176.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.661 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 91.4 m -71.92 141.19 49.48 Favored 'General case' 0 CA--C 1.558 1.285 0 N-CA-C 115.181 1.548 . . . . 0.0 115.181 -174.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 15.1 p80 -73.08 155.8 39.37 Favored 'General case' 0 CA--C 1.577 2.016 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 37.3 m . . . . . 0 CA--C 1.56 1.334 0 CA-C-O 124.883 2.278 . . . . 0.0 112.785 -170.653 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.277 53.6 t . . . . . 0 N--CA 1.494 1.757 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.492 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 19.3 p -152.24 -155.92 0.66 Allowed 'General case' 0 CA--C 1.574 1.867 0 C-N-CA 124.423 1.089 . . . . 0.0 113.033 -165.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 14.8 t -80.69 -54.86 5.26 Favored 'General case' 0 CA--C 1.574 1.904 0 N-CA-C 116.263 1.949 . . . . 0.0 116.263 160.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -127.37 85.94 0.33 Allowed Glycine 0 N--CA 1.495 2.581 0 CA-C-N 120.69 1.586 . . . . 0.0 115.936 -165.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.704 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 16.6 t80 -170.82 155.09 4.56 Favored Pre-proline 0 CA--C 1.583 2.241 0 C-N-CA 124.718 1.207 . . . . 0.0 110.004 -173.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -33.89 -48.94 0.54 Allowed 'Trans proline' 0 CA--C 1.566 2.116 0 N-CA-C 121.962 3.793 . . . . 0.0 121.962 173.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 8.3 mp -86.86 -13.1 45.9 Favored 'General case' 0 CA--C 1.578 2.048 0 N-CA-C 116.617 2.081 . . . . 0.0 116.617 178.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.704 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 66.3 m -70.16 166.03 20.81 Favored 'General case' 0 CA--C 1.565 1.536 0 N-CA-C 118.003 2.594 . . . . 0.0 118.003 -162.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 27.3 p80 -86.57 163.65 17.33 Favored 'General case' 0 CA--C 1.579 2.064 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 -178.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 72.5 m . . . . . 0 CA--C 1.562 1.44 0 CA-C-O 124.633 2.159 . . . . 0.0 115.503 -168.899 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.292 73.5 t . . . . . 0 N--CA 1.493 1.693 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.47 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 17.0 p -147.45 -151.2 0.37 Allowed 'General case' 0 CA--C 1.575 1.933 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -161.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 11.9 t -87.51 -45.19 10.7 Favored 'General case' 0 CA--C 1.576 1.959 0 N-CA-C 115.877 1.806 . . . . 0.0 115.877 154.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -123.73 75.12 0.38 Allowed Glycine 0 N--CA 1.495 2.63 0 N-CA-C 117.253 1.661 . . . . 0.0 117.253 -167.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.649 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 2.3 t80 -167.62 152.64 6.77 Favored Pre-proline 0 CA--C 1.584 2.262 0 C-N-CA 124.939 1.296 . . . . 0.0 108.956 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -31.0 -54.69 0.24 Allowed 'Trans proline' 0 CA--C 1.569 2.274 0 N-CA-C 122.38 3.954 . . . . 0.0 122.38 173.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.1 mp -85.19 4.8 32.88 Favored 'General case' 0 CA--C 1.585 2.325 0 N-CA-C 116.682 2.104 . . . . 0.0 116.682 178.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.649 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 82.3 m -77.09 144.72 38.31 Favored 'General case' 0 CA--C 1.562 1.441 0 O-C-N 119.602 -1.936 . . . . 0.0 116.012 -167.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 35.5 p80 -66.92 166.05 14.25 Favored 'General case' 0 CA--C 1.584 2.261 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 171.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 76.3 m . . . . . 0 CA--C 1.56 1.362 0 CA-C-O 124.62 2.153 . . . . 0.0 114.375 -173.605 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.281 40.7 t . . . . . 0 N--CA 1.496 1.838 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.479 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 17.6 p -150.94 -147.32 0.23 Allowed 'General case' 0 CA--C 1.575 1.935 0 C-N-CA 124.116 0.966 . . . . 0.0 113.523 -164.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 20.8 t -93.79 -56.46 2.88 Favored 'General case' 0 CA--C 1.577 2.007 0 O-C-N 120.733 -1.23 . . . . 0.0 114.051 153.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -108.25 77.34 0.23 Allowed Glycine 0 N--CA 1.498 2.796 0 N-CA-C 118.293 2.077 . . . . 0.0 118.293 -169.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.698 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 12.0 t80 -167.09 155.95 9.32 Favored Pre-proline 0 CA--C 1.589 2.461 0 C-N-CA 124.691 1.196 . . . . 0.0 109.915 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -36.06 -46.7 1.05 Allowed 'Trans proline' 0 CA--C 1.567 2.153 0 N-CA-C 122.378 3.953 . . . . 0.0 122.378 172.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.4 mp -86.06 -4.71 59.23 Favored 'General case' 0 CA--C 1.578 2.029 0 N-CA-C 116.083 1.883 . . . . 0.0 116.083 177.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.698 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 95.5 m -75.72 149.37 38.07 Favored 'General case' 0 CA--C 1.564 1.495 0 N-CA-C 117.43 2.381 . . . . 0.0 117.43 -163.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 34.3 p80 -81.55 172.36 13.57 Favored 'General case' 0 CA--C 1.581 2.148 0 N-CA-C 114.927 1.454 . . . . 0.0 114.927 -179.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 86.5 m . . . . . 0 N--CA 1.484 1.258 0 CA-C-O 125.358 2.504 . . . . 0.0 116.234 -166.372 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.303 24.6 t . . . . . 0 N--CA 1.492 1.659 0 N-CA-C 111.205 0.076 . . . . 0.0 111.205 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.401 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 18.0 p -146.68 -147.49 0.22 Allowed 'General case' 0 CA--C 1.573 1.86 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -160.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 5.8 t -89.18 -49.01 7.0 Favored 'General case' 0 CA--C 1.574 1.878 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 155.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -120.61 72.46 0.35 Allowed Glycine 0 N--CA 1.495 2.619 0 N-CA-C 118.073 1.989 . . . . 0.0 118.073 -166.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.61 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 2.5 t80 -165.14 157.75 13.68 Favored Pre-proline 0 CA--C 1.591 2.54 0 C-N-CA 124.776 1.23 . . . . 0.0 109.132 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -35.75 -49.89 1.03 Allowed 'Trans proline' 0 CA--C 1.566 2.097 0 N-CA-C 122.001 3.808 . . . . 0.0 122.001 172.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 9.1 mp -76.79 -14.56 59.91 Favored 'General case' 0 CA--C 1.579 2.07 0 N-CA-C 116.401 2.001 . . . . 0.0 116.401 175.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.61 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 97.6 m -69.16 148.47 49.88 Favored 'General case' 0 CA--C 1.567 1.631 0 N-CA-C 118.007 2.595 . . . . 0.0 118.007 -162.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 34.0 p80 -83.81 171.01 13.53 Favored 'General case' 0 CA--C 1.581 2.172 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 176.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 77.7 m . . . . . 0 N--CA 1.481 1.082 0 CA-C-O 124.392 2.044 . . . . 0.0 112.71 -172.397 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.317 72.2 t . . . . . 0 CA--C 1.569 1.688 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.419 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 20.3 p -137.19 -147.07 0.23 Allowed 'General case' 0 CA--C 1.574 1.9 0 C-N-CA 124.463 1.105 . . . . 0.0 113.861 -162.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 45.7 t -112.61 118.98 36.57 Favored 'General case' 0 CA--C 1.57 1.724 0 O-C-N 120.248 -1.532 . . . . 0.0 110.577 151.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 100.42 64.74 0.8 Allowed Glycine 0 N--CA 1.499 2.895 0 N-CA-C 117.811 1.884 . . . . 0.0 117.811 169.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.688 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 22.6 t80 -179.15 151.1 0.64 Allowed Pre-proline 0 CA--C 1.588 2.419 0 C-N-CA 125.272 1.429 . . . . 0.0 108.66 -172.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -34.45 -58.94 0.34 Allowed 'Trans proline' 0 CA--C 1.568 2.221 0 C-N-CA 124.593 3.529 . . . . 0.0 120.931 172.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.8 mp -78.45 -9.48 59.32 Favored 'General case' 0 CA--C 1.583 2.214 0 N-CA-C 116.232 1.938 . . . . 0.0 116.232 177.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.688 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 68.3 m -71.42 151.69 43.79 Favored 'General case' 0 CA--C 1.563 1.475 0 N-CA-C 116.774 2.138 . . . . 0.0 116.774 -169.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 29.4 p80 -88.85 165.38 14.69 Favored 'General case' 0 CA--C 1.581 2.143 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -179.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 51.3 m . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 124.918 2.294 . . . . 0.0 114.622 -162.597 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.303 31.9 t . . . . . 0 N--CA 1.494 1.727 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.425 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 16.8 p -147.64 -158.11 0.88 Allowed 'General case' 0 CA--C 1.576 1.962 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 -162.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 29.3 t -104.95 98.06 7.83 Favored 'General case' 0 CA--C 1.574 1.887 0 O-C-N 120.635 -1.29 . . . . 0.0 111.523 147.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 113.81 69.09 0.5 Allowed Glycine 0 N--CA 1.501 2.996 0 N-CA-C 117.692 1.837 . . . . 0.0 117.692 170.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.622 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 1.4 t80 -175.81 154.69 1.51 Allowed Pre-proline 0 CA--C 1.589 2.47 0 C-N-CA 125.612 1.565 . . . . 0.0 108.144 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -32.85 -51.75 0.4 Allowed 'Trans proline' 0 CA--C 1.569 2.237 0 N-CA-C 121.898 3.768 . . . . 0.0 121.898 173.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.9 mp -84.71 -0.64 54.31 Favored 'General case' 0 CA--C 1.582 2.187 0 N-CA-C 116.213 1.931 . . . . 0.0 116.213 177.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.622 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 92.3 m -77.88 146.43 35.63 Favored 'General case' 0 CA--C 1.564 1.503 0 O-C-N 119.478 -2.014 . . . . 0.0 116.383 -165.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 21.2 p80 -80.21 161.0 25.42 Favored 'General case' 0 CA--C 1.579 2.075 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 175.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 73.1 m . . . . . 0 N--CA 1.483 1.207 0 CA-C-O 125.441 2.543 . . . . 0.0 116.008 -166.189 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.43 ' HB ' ' SG ' ' A' ' 8' ' ' CYS 0.265 55.4 t . . . . . 0 N--CA 1.495 1.807 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.447 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 19.5 p -159.42 -159.47 0.75 Allowed 'General case' 0 CA--C 1.575 1.936 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -161.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 53.4 t -100.26 132.44 45.62 Favored 'General case' 0 CA--C 1.575 1.932 0 O-C-N 120.307 -1.496 . . . . 0.0 112.224 142.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 93.22 57.32 1.38 Allowed Glycine 0 N--CA 1.499 2.899 0 N-CA-C 118.155 2.022 . . . . 0.0 118.155 165.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.668 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 26.2 t80 -173.44 155.88 2.75 Favored Pre-proline 0 CA--C 1.584 2.257 0 CA-C-N 118.597 1.198 . . . . 0.0 110.682 -170.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -36.27 -56.98 0.61 Allowed 'Trans proline' 0 CA--C 1.568 2.182 0 N-CA-C 121.076 3.452 . . . . 0.0 121.076 171.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.3 mp -82.47 -6.43 59.3 Favored 'General case' 0 CA--C 1.58 2.115 0 N-CA-C 116.765 2.135 . . . . 0.0 116.765 178.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.668 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 74.3 m -75.39 150.69 38.3 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 116.796 2.147 . . . . 0.0 116.796 -165.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 23.9 p80 -81.92 166.27 20.03 Favored 'General case' 0 CA--C 1.579 2.07 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 59.8 m . . . . . 0 N--CA 1.483 1.187 0 CA-C-O 125.171 2.415 . . . . 0.0 112.381 -169.975 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.297 55.4 t . . . . . 0 CA--C 1.572 1.79 0 N-CA-C 111.355 0.132 . . . . 0.0 111.355 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 17.1 p -148.18 -148.91 0.27 Allowed 'General case' 0 CA--C 1.578 2.031 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 -163.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 41.2 t -124.52 66.42 1.08 Allowed 'General case' 0 CA--C 1.579 2.095 0 O-C-N 120.793 -1.192 . . . . 0.0 112.366 160.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 150.02 61.13 0.01 OUTLIER Glycine 0 N--CA 1.502 3.063 0 N-CA-C 117.393 1.717 . . . . 0.0 117.393 177.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.66 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 3.6 t80 -172.7 153.57 2.74 Favored Pre-proline 0 CA--C 1.588 2.41 0 C-N-CA 125.137 1.375 . . . . 0.0 109.094 -176.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -33.53 -54.86 0.44 Allowed 'Trans proline' 0 CA--C 1.564 2.021 0 N-CA-C 121.971 3.797 . . . . 0.0 121.971 173.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.8 mp -81.0 -10.44 59.71 Favored 'General case' 0 CA--C 1.577 2.018 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 176.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.66 ' SG ' ' HB3' ' A' ' 5' ' ' TYR . 93.7 m -67.01 138.63 57.36 Favored 'General case' 0 CA--C 1.56 1.345 0 N-CA-C 115.987 1.847 . . . . 0.0 115.987 -168.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 18.6 p80 -74.15 156.89 36.87 Favored 'General case' 0 CA--C 1.577 2.003 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 -179.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 11.0 m . . . . . 0 CA--C 1.562 1.428 0 CA-C-O 124.991 2.329 . . . . 0.0 112.943 -173.559 . . . . . . . . 0 0 . 1 stop_ save_